Identification	O
of	O
a	O
killer	B-DNA
cell-specific	I-DNA
regulatory	I-DNA
element	I-DNA
of	O
the	O
mouse	B-DNA
perforin	I-DNA
gene	I-DNA
:	O
an	O
Ets-binding	O
site-homologous	O
motif	O
that	O
interacts	O
with	O
Ets-related	B-protein
proteins	I-protein
.	O

The	O
gene	O
encoding	O
the	O
cytolytic	B-protein
protein	I-protein
perforin	B-protein
is	O
selectively	O
expressed	O
by	O
activated	B-cell_type
killer	I-cell_type
lymphocytes	I-cell_type
.	O

To	O
understand	O
the	O
mechanisms	O
underlying	O
the	O
cell-type-specific	O
expression	O
of	O
this	O
gene	O
,	O
we	O
have	O
characterized	O
the	O
regulatory	O
functions	O
and	O
the	O
DNA-protein	O
interactions	O
of	O
the	O
5'-flanking	B-DNA
region	I-DNA
of	O
the	O
mouse	B-DNA
perforin	I-DNA
gene	I-DNA
(	O
Pfp	B-DNA
)	O
.	O

A	O
region	O
extending	O
from	O
residues	B-DNA
+62	I-DNA
through	I-DNA
-141	I-DNA
,	O
which	O
possesses	O
the	O
essential	O
promoter	O
activity	O
,	O
and	O
regions	O
further	O
upstream	O
,	O
which	O
are	O
able	O
to	O
either	O
enhance	O
or	O
suppress	O
gene	O
expression	O
,	O
were	O
identified	O
.	O

The	O
region	O
between	O
residues	B-DNA
-411	I-DNA
and	I-DNA
-566	I-DNA
was	O
chosen	O
for	O
further	O
characterization	O
,	O
since	O
it	O
contains	O
an	O
enhancer-like	O
activity	O
.	O

We	O
have	O
identified	O
a	O
32-mer	O
sequence	O
(	O
residues	B-DNA
-491	I-DNA
to	I-DNA
-522	I-DNA
)	O
which	O
appeared	O
to	O
be	O
capable	O
of	O
enhancing	O
gene	O
expression	O
in	O
a	O
killer	O
cell-specific	O
manner	O
.	O

Within	O
this	O
segment	O
,	O
a	O
9-mer	O
motif	O
(	O
5'-ACAGGAAGT-3	O
'	O
,	O
residues	B-DNA
-505	I-DNA
to	I-DNA
-497	I-DNA
;	O
designated	O
NF-P	O
motif	O
)	O
,	O
which	O
is	O
highly	O
homologous	O
to	O
the	O
Ets	B-DNA
proto-oncoprotein-binding	I-DNA
site	I-DNA
,	O
was	O
found	O
to	O
interact	O
with	O
two	O
proteins	O
,	O
NF-P1	B-protein
and	O
NF-P2	B-protein
.	O

NF-P2	B-protein
appears	O
to	O
be	O
induced	O
by	O
reagents	O
known	O
to	O
up-regulate	O
the	O
perforin	O
message	O
level	O
and	O
is	O
present	O
exclusively	O
in	O
killer	B-cell_type
cells	I-cell_type
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
and	O
UV	O
cross-linking	O
experiments	O
revealed	O
that	O
NF-P1	B-protein
and	O
NF-P2	B-protein
may	O
possess	O
common	O
DNA-binding	B-protein
subunits	I-protein
.	O

However	O
,	O
the	O
larger	O
native	O
molecular	O
mass	O
of	O
NF-P1	B-protein
suggests	O
that	O
NF-P1	B-protein
contains	O
an	O
additional	O
non-DNA-binding	B-protein
subunit	I-protein
(	O
s	O
)	O
.	O

In	O
view	O
of	O
the	O
homology	O
between	O
the	O
NF-P	B-protein
motif	I-protein
and	O
other	O
Ets	B-protein
proto-oncoprotein-binding	I-protein
sites	I-protein
,	O
it	O
is	O
postulated	O
that	O
NF-P1	B-protein
and	O
NF-P2	B-protein
belong	O
to	O
the	O
Ets	B-protein
protein	I-protein
family	I-protein
.	O

Results	O
obtained	O
from	O
the	O
binding	O
competition	O
assay	O
,	O
nevertheless	O
,	O
suggest	O
that	O
NF-P1	B-protein
and	O
NF-P2	B-protein
are	O
related	O
to	O
but	O
distinct	O
from	O
Ets	B-protein
proteins	I-protein
,	O
e.g.	O
,	O
Ets-1	B-protein
,	O
Ets-2	B-protein
,	O
and	O
NF-AT/Elf-1	B-protein
,	O
known	O
to	O
be	O
expressed	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
Nov.	NULL
1993	NULL
,	NULL
p.	NULL
6690-6701	NULL
0270-7306/93/116690-12	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
Â©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Identification	NULL
of	NULL
a	NULL
Killer	NULL
Cell-Specific	NULL
Regulatory	NULL
Element	NULL
of	NULL
the	NULL
Mouse	NULL
Perforin	NULL
Gene	NULL
:	NULL
an	NULL
Ets-Binding	NULL
Site-Homologous	NULL
Motif	NULL
That	NULL
Interacts	NULL
with	NULL
Ets-Related	NULL
Proteins	NULL
HIROTAKA	NULL
KOIZUMI	NULL
,	NULL
'+	NULL
M.	NULL
FATIMA	NULL
HORTA	NULL
,	NULL
'	NULL
BYUNG-S.	NULL
YOUN	NULL
,	NULL
``	NULL
KOK-CHIN	NULL
FU	NULL
,	NULL
!	NULL

BYOUNG	NULL
S.	NULL
KWON	NULL
,	NULL
*	NULL
JOHN	NULL
DING-E	NULL
YOUNG	NULL
,	NULL
``	NULL
anp	NULL
CHAU-CHING	NULL
LIU'*	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Immunology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
The	NULL
Rockefeller	NULL
University	NULL
,	NULL
1230	NULL
York	NULL
Avenue	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10021	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Indiana	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Indianapolis	NULL
,	NULL
Indiana	NULL
46202	NULL
Received	NULL
11	NULL
March	NULL
1993/Returned	NULL
for	NULL
modification	NULL
29	NULL
April	NULL
1993/Accepted	NULL
9	NULL
August	NULL
1993	NULL
The	NULL
gene	NULL
encoding	NULL
the	NULL
cytolytic	NULL
protein	NULL
perforin	NULL
is	NULL
selectively	NULL
expressed	NULL
by	NULL
activated	NULL
killer	NULL
lymphocytes	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
mechanisms	NULL
underlying	NULL
the	NULL
cell-type-specific	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
regulatory	NULL
functions	NULL
and	NULL
the	NULL
DNA-protein	NULL
interactions	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
perforin	NULL
gene	NULL
(	NULL
Pfp	NULL
)	NULL
.	NULL

A	NULL
region	NULL
extending	NULL
from	NULL
residues	NULL
+62	NULL
through	NULL
-141	NULL
,	NULL
which	NULL
possesses	NULL
the	NULL
essential	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
regions	NULL
further	NULL
upstream	NULL
,	NULL
which	NULL
are	NULL
able	NULL
to	NULL
either	NULL
enhance	NULL
or	NULL
suppress	NULL
gene	NULL
expression	NULL
,	NULL
were	NULL
identified	NULL
.	NULL

The	NULL
region	NULL
between	NULL
residues	NULL
-411	NULL
and	NULL
-566	NULL
was	NULL
chosen	NULL
for	NULL
further	NULL
characterization	NULL
,	NULL
since	NULL
it	NULL
contains	NULL
an	NULL
enhancer-like	NULL
activity	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
32-mer	NULL
sequence	NULL
(	NULL
residues	NULL
-491	NULL
to	NULL
-522	NULL
)	NULL
which	NULL
appeared	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
enhancing	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
killer	NULL
cell-specific	NULL
manner	NULL
.	NULL

Within	NULL
this	NULL
segment	NULL
,	NULL
a	NULL
9-mer	NULL
motif	NULL
(	NULL
5'-ACAGGAAGT-3	NULL
'	NULL
,	NULL
residues	NULL
-505	NULL
to	NULL
-497	NULL
;	NULL
designated	NULL
NF-P	NULL
motif	NULL
)	NULL
,	NULL
which	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
Ets	NULL
proto-oncoprotein-binding	NULL
site	NULL
,	NULL
was	NULL
found	NULL
to	NULL
interact	NULL
with	NULL
two	NULL
proteins	NULL
,	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

NF-P2	NULL
appears	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
reagents	NULL
known	NULL
to	NULL
up-regulate	NULL
the	NULL
perforin	NULL
message	NULL
level	NULL
and	NULL
is	NULL
present	NULL
exclusively	NULL
in	NULL
killer	NULL
cells	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
and	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
revealed	NULL
that	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
may	NULL
possess	NULL
common	NULL
DNA-binding	NULL
subunits	NULL
.	NULL

However	NULL
,	NULL
the	NULL
larger	NULL
native	NULL
molecular	NULL
mass	NULL
of	NULL
NF-P1	NULL
suggests	NULL
that	NULL
NF-P1	NULL
contains	NULL
an	NULL
additional	NULL
non-DNA-binding	NULL
subunit	NULL
(	NULL
s	NULL
)	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
homology	NULL
between	NULL
the	NULL
NF-P	NULL
motif	NULL
and	NULL
other	NULL
Ets	NULL
proto-oncoprotein-binding	NULL
sites	NULL
,	NULL
it	NULL
is	NULL
postulated	NULL
that	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
belong	NULL
to	NULL
the	NULL
Ets	NULL
protein	NULL
family	NULL
.	NULL

Results	NULL
obtained	NULL
from	NULL
the	NULL
binding	NULL
competition	NULL
assay	NULL
,	NULL
nevertheless	NULL
,	NULL
suggest	NULL
that	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
are	NULL
related	NULL
to	NULL
but	NULL
distinct	NULL
from	NULL
Ets	NULL
proteins	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
Ets-1	NULL
,	NULL
Ets-2	NULL
,	NULL
and	NULL
NF-AT/EIf-1	NULL
,	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Perforin	NULL
,	NULL
the	NULL
pore-forming	NULL
protein	NULL
(	NULL
PFP	NULL
)	NULL
,	NULL
is	NULL
a	NULL
cytolytic	NULL
protein	NULL
specifically	NULL
expressed	NULL
in	NULL
killer	NULL
lymphocytes	NULL
,	NULL
including	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
(	NULL
CTL	NULL
)	NULL
,	NULL
natural	NULL
killer	NULL
cells	NULL
,	NULL
lymphokine-activated	NULL
killer	NULL
(	NULL
LAK	NULL
)	NULL
cells	NULL
,	NULL
and	NULL
4/8	NULL
T	NULL
cells	NULL
.	NULL

Together	NULL
with	NULL
other	NULL
effector	NULL
molecules	NULL
,	NULL
PFP	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
lymphocyte-mediated	NULL
cytotoxicity	NULL
by	NULL
forming	NULL
transmembrane	NULL
pores	NULL
that	NULL
lead	NULL
to	NULL
target	NULL
cell	NULL
lysis	NULL
(	NULL
18	NULL
,	NULL
32	NULL
,	NULL
42	NULL
,	NULL
48	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
perforin	NULL
message	NULL
level	NULL
can	NULL
be	NULL
up-regulated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
T-cell	NULL
activators	NULL
such	NULL
as	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
,	NULL
lectins	NULL
,	NULL
and	NULL
phorbol	NULL
ester	NULL
and	NULL
is	NULL
partially	NULL
down-regulated	NULL
by	NULL
the	NULL
immunosuppressive	NULL
drug	NULL
cyclosporin	NULL
A	NULL
(	NULL
15	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Results	NULL
obtained	NULL
from	NULL
these	NULL
studies	NULL
,	NULL
however	NULL
,	NULL
provided	NULL
no	NULL
clues	NULL
to	NULL
the	NULL
mechanisms	NULL
that	NULL
control	NULL
the	NULL
cell-type-specific	NULL
expression	NULL
of	NULL
the	NULL
perforin	NULL
gene	NULL
(	NULL
Pfp	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
genomic	NULL
organizations	NULL
of	NULL
mouse	NULL
and	NULL
human	NULL
Pfp	NULL
have	NULL
been	NULL
defined	NULL
(	NULL
21	NULL
,	NULL
41	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Their	NULL
5'-flanking	NULL
sequences	NULL
,	NULL
being	NULL
homologous	NULL
to	NULL
each	NULL
other	NULL
,	NULL
share	NULL
also	NULL
some	NULL
homology	NULL
with	NULL
known	NULL
cis-acting	NULL
elements	NULL
(	NULL
21	NULL
,	NULL
47	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
mouse	NULL
Pfp	NULL
,	NULL
these	NULL
include	NULL
TATA	NULL
box-	NULL
and	NULL
GC	NULL
box-related	NULL
promoter	NULL
sequences	NULL
;	NULL
cyclic	NULL
AMP-	NULL
,	NULL
phorbol	NULL
es-ter-	NULL
,	NULL
and	NULL
gamma	NULL
interferon-responsive	NULL
site-like	NULL
elements	NULL
;	NULL
and	NULL
NF-	NULL
Â«	NULL
B	NULL
binding	NULL
site-like	NULL
elements	NULL
(	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
appears	NULL
that	NULL
these	NULL
potential	NULL
elements	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

t	NULL
Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Pathology	NULL
II	NULL
,	NULL
St.	NULL
Marianna	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
2-16-1	NULL
Sugao	NULL
,	NULL
Miyamae-Ku	NULL
,	NULL
Kawasaki	NULL
216	NULL
,	NULL
Japan	NULL
.	NULL

6690	NULL
and	NULL
their	NULL
cognate	NULL
trans-acting	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
regulating	NULL
the	NULL
transcription	NULL
of	NULL
Pfp	NULL
,	NULL
virtually	NULL
no	NULL
information	NULL
is	NULL
available	NULL
concerning	NULL
the	NULL
regulatory	NULL
functions	NULL
and	NULL
the	NULL
DNA-protein	NULL
interactions	NULL
of	NULL
the	NULL
Pfp	NULL
5'-flanking	NULL
region	NULL
.	NULL

The	NULL
tissue-	NULL
and	NULL
cell-specific	NULL
manner	NULL
of	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
rely	NULL
primarily	NULL
on	NULL
the	NULL
combined	NULL
actions	NULL
of	NULL
various	NULL
transcription	NULL
factors	NULL
.	NULL

These	NULL
transcription	NULL
factors	NULL
may	NULL
interact	NULL
with	NULL
their	NULL
cognate	NULL
regulatory	NULL
sequences	NULL
(	NULL
pro-moters	NULL
,	NULL
enhancers	NULL
,	NULL
or	NULL
silencers	NULL
)	NULL
of	NULL
the	NULL
gene	NULL
to	NULL
be	NULL
transcribed	NULL
(	NULL
27	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
multiple	NULL
regulatory	NULL
elements	NULL
allows	NULL
specific	NULL
transcription	NULL
factors	NULL
to	NULL
initiate	NULL
efficient	NULL
transcription	NULL
in	NULL
a	NULL
coordinated	NULL
manner	NULL
within	NULL
a	NULL
cell	NULL
at	NULL
different	NULL
times	NULL
during	NULL
its	NULL
growth	NULL
,	NULL
differentiation	NULL
,	NULL
or	NULL
activation	NULL
.	NULL

Mechanisms	NULL
that	NULL
control	NULL
the	NULL
expression	NULL
of	NULL
lymphocyte-specific	NULL
genes	NULL
have	NULL
recently	NULL
been	NULL
elucidated	NULL
,	NULL
mainly	NULL
through	NULL
the	NULL
studies	NULL
on	NULL
T-cell	NULL
receptor	NULL
and	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
T-	NULL
or	NULL
B-cell-specific	NULL
nuclear	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
TCF-1/LEF-1	NULL
,	NULL
GATA-3	NULL
,	NULL
and	NULL
OTF-2/Oct-2	NULL
,	NULL
are	NULL
involved	NULL
in	NULL
restricting	NULL
the	NULL
expression	NULL
of	NULL
T-cell	NULL
receptor	NULL
or	NULL
immunoglobulin	NULL
genes	NULL
to	NULL
lymphocytes	NULL
by	NULL
interacting	NULL
with	NULL
their	NULL
cognate	NULL
cis-acting	NULL
elements	NULL
(	NULL
20	NULL
,	NULL
35	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
premise	NULL
that	NULL
killer	NULL
lymphocytes	NULL
should	NULL
also	NULL
contain	NULL
their	NULL
particular	NULL
transcription	NULL
factors	NULL
to	NULL
regulate	NULL
Pfp	NULL
expression	NULL
,	NULL
we	NULL
have	NULL
attempted	NULL
to	NULL
localize	NULL
the	NULL
functional	NULL
DNA	NULL
sequences	NULL
which	NULL
control	NULL
Pfp	NULL
expression	NULL
in	NULL
killer	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
report	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
and	NULL
several	NULL
additional	NULL
upstream	NULL
regulatory	NULL
sequences	NULL
of	NULL
Pfp	NULL
.	NULL

Among	NULL
these	NULL
sequences	NULL
,	NULL
a	NULL
32-bp	NULL
segment	NULL
(	NULL
residues	NULL
-522	NULL
to	NULL
-491	NULL
)	NULL
appears	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
driving	NULL
gene	NULL
expres-	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
sion	NULL
in	NULL
a	NULL
killer	NULL
cell-specific	NULL
fashion	NULL
.	NULL

This	NULL
segment	NULL
contains	NULL
a	NULL
9-mer	NULL
motif	NULL
located	NULL
between	NULL
residues	NULL
-505	NULL
and	NULL
-497	NULL
which	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
Ets	NULL
proto-oncoprotein-binding	NULL
site	NULL
(	NULL
EBS	NULL
)	NULL
.	NULL

We	NULL
present	NULL
results	NULL
suggesting	NULL
that	NULL
this	NULL
9-mer	NULL
motif	NULL
probably	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
controlling	NULL
Pfp	NULL
expression	NULL
in	NULL
killer	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

Murine	NULL
cell	NULL
lines	NULL
P815	NULL
(	NULL
mastocytoma	NULL
)	NULL
,	NULL
YAC-1	NULL
(	NULL
T-cell	NULL
leukemia	NULL
)	NULL
,	NULL
and	NULL
EL-4	NULL
(	NULL
thymoma	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
a	NULL
Â«	NULL
-modified	NULL
minimal	NULL
essential	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
,	NULL
Logan	NULL
,	NULL
Utah	NULL
)	NULL
and	NULL
antibiotics	NULL
.	NULL

IL-2-dependent	NULL
CTL	NULL
lines	NULL
CTLL-R8	NULL
and	NULL
CTLL-2	NULL
were	NULL
further	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
conditioned	NULL
medium	NULL
[	NULL
the	NULL
culture	NULL
supernatant	NULL
of	NULL
rat	NULL
splenocytes	NULL
stimulated	NULL
for	NULL
48	NULL
h	NULL
with	NULL
10	NULL
mg	NULL
of	NULL
concanavalin	NULL
A	NULL
(	NULL
ConA	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

per	NULL
ml	NULL
and	NULL
20	NULL
ng	NULL
of	NULL
phorbol	NULL
myristyl	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
]	NULL
(	NULL
15	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
resting	NULL
CTLL-R8	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
depriving	NULL
confluent	NULL
R8	NULL
cells	NULL
of	NULL
the	NULL
conditioned	NULL
medium	NULL
for	NULL
1	NULL
week	NULL
prior	NULL
to	NULL
being	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
EL-4	NULL
and	NULL
resting	NULL
CTLL-R8	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
100	NULL
U	NULL
of	NULL
recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
Cetus	NULL
Corp.	NULL
,	NULL
Emeryville	NULL
,	NULL
Calif.	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
ConA	NULL
and	NULL
PMA	NULL
(	NULL
10	NULL
mg	NULL
and	NULL
20	NULL
ng	NULL
,	NULL
respectively	NULL
,	NULL
per	NULL
ml	NULL
)	NULL
,	NULL
or	NULL
10	NULL
%	NULL
conditioned	NULL
medium	NULL
.	NULL

Murine	NULL
spleens	NULL
and	NULL
livers	NULL
were	NULL
obtained	NULL
from	NULL
young	NULL
C57BL/6	NULL
mice	NULL
.	NULL

Adherent	NULL
LAK	NULL
cells	NULL
were	NULL
derived	NULL
from	NULL
nylon-wool-purified	NULL
splenic	NULL
T	NULL
cells	NULL
(	NULL
15	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Plasmid	NULL
constructs	NULL
.	NULL

A	NULL
panel	NULL
of	NULL
plasmid	NULL
constructs	NULL
containing	NULL
sequential	NULL
deletion	NULL
of	NULL
the	NULL
Pfp	NULL
5'-flanking	NULL
sequence	NULL
fused	NULL
to	NULL
a	NULL
reporter	NULL
gene	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
,	NULL
was	NULL
prepared	NULL
.	NULL

An	NULL
artificial	NULL
fragment	NULL
of	NULL
Pfp	NULL
5'-flanking	NULL
region	NULL
was	NULL
generated	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
with	NULL
a	NULL
5	NULL
'	NULL
primer	NULL
that	NULL
incorporated	NULL
a	NULL
SacI	NULL
site	NULL
into	NULL
the	NULL
sequence	NULL
encoding	NULL
residues	NULL
-700	NULL
through	NULL
-684	NULL
of	NULL
the	NULL
mouse	NULL
Pfp	NULL
and	NULL
a	NULL
3	NULL
'	NULL
primer	NULL
complementary	NULL
to	NULL
residues	NULL
+45	NULL
through	NULL
+62	NULL
plus	NULL
a	NULL
HindIII	NULL
site	NULL
.	NULL

The	NULL
PCR-amplified	NULL
fragments	NULL
were	NULL
digested	NULL
with	NULL
Sacl	NULL
and	NULL
HindIII	NULL
and	NULL
then	NULL
cloned	NULL
into	NULL
a	NULL
SaclI-HindIII-digested	NULL
pSVCAT	NULL
vector	NULL
which	NULL
contains	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
and	NULL
the	NULL
CAT	NULL
gene	NULL
so	NULL
that	NULL
the	NULL
Pfp	NULL
5	NULL
'	NULL
sequence	NULL
would	NULL
be	NULL
located	NULL
upstream	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
and	NULL
downstream	NULL
to	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
.	NULL

To	NULL
create	NULL
shorter	NULL
deletional	NULL
constructs	NULL
,	NULL
the	NULL
original	NULL
reporter	NULL
construct	NULL
was	NULL
linearized	NULL
with	NULL
SacI	NULL
!	NULL

and	NULL
digested	NULL
with	NULL
Bal	NULL
31	NULL
nuclease	NULL
for	NULL
different	NULL
lengths	NULL
of	NULL
time	NULL
,	NULL
and	NULL
the	NULL
inserts	NULL
were	NULL
released	NULL
by	NULL
HindIII	NULL
digestion	NULL
,	NULL
purified	NULL
,	NULL
and	NULL
polished	NULL
by	NULL
SacI	NULL
linker	NULL
ligation	NULL
and	NULL
then	NULL
by	NULL
SacI	NULL
digestion	NULL
.	NULL

The	NULL
shortened	NULL
inserts	NULL
were	NULL
finally	NULL
ligated	NULL
into	NULL
Sacl-HindlII-digested	NULL
pSVCAT	NULL
vector	NULL
,	NULL
and	NULL
the	NULL
precise	NULL
5	NULL
'	NULL
edge	NULL
of	NULL
the	NULL
Pfp	NULL
regulatory	NULL
sequence	NULL
in	NULL
each	NULL
prepared	NULL
construct	NULL
was	NULL
determined	NULL
by	NULL
nucleotide	NULL
sequencing	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
longer	NULL
insert	NULL
was	NULL
cleaved	NULL
with	NULL
Pvull	NULL
enzyme	NULL
at	NULL
residues	NULL
-522	NULL
and	NULL
-141	NULL
,	NULL
and	NULL
the	NULL
desired	NULL
fragment	NULL
was	NULL
purified	NULL
,	NULL
polished	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
vector	NULL
.	NULL

This	NULL
series	NULL
of	NULL
reporter	NULL
plasmids	NULL
was	NULL
designated	NULL
pCAToco	NULL
(	NULL
ooo	NULL
indicates	NULL
the	NULL
5'Â°	NULL
edge	NULL
of	NULL
the	NULL
Pfp	NULL
sequence	NULL
incorporated	NULL
)	NULL
constructs	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
function	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
,	NULL
two	NULL
types	NULL
of	NULL
constructs	NULL
were	NULL
prepared	NULL
.	NULL

An	NULL
oligonucleotide	NULL
encoding	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
Pvull-KpnI	NULL
fragment	NULL
sequence	NULL
(	NULL
residues	NULL
-522	NULL
through	NULL
-491	NULL
)	NULL
in	NULL
tandem	NULL
was	NULL
synthesized	NULL
and	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
Pfp	NULL
5	NULL
'	NULL
sequence	NULL
in	NULL
pCAT_	NULL
,	NULL
,	NULL
,	NULL
(	NULL
containing	NULL
Pfp	NULL
5	NULL
'	NULL
sequence	NULL
up	NULL
to	NULL
residue	NULL
-411	NULL
)	NULL
.	NULL

DNA	NULL
fragments	NULL
containing	NULL
mutation	NULL
within	NULL
the	NULL
NF-P	NULL
motif	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
the	NULL
universal	NULL
3	NULL
'	NULL
primer	NULL
and	NULL
mutated	NULL
oligonucleotides	NULL
(	NULL
M2	NULL
and	NULL
M3	NULL
[	NULL
see	NULL
be-low	NULL
]	NULL
)	NULL
as	NULL
the	NULL
5	NULL
'	NULL
primer	NULL
.	NULL

These	NULL
fragments	NULL
(	NULL
corresponding	NULL
to	NULL
KILLER	NULL
CELL-SPECIFIC	NULL
REGULATORY	NULL
ELEMENT	NULL
OF	NULL
MOUSE	NULL
Pfp	NULL
6691	NULL
residues	NULL
-522	NULL
through	NULL
+62	NULL
of	NULL
the	NULL
Pfp	NULL
sequence	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
pSVCAT	NULL
vector	NULL
,	NULL
and	NULL
mutations	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
were	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

DNA	NULL
transfection	NULL
.	NULL

Plasmids	NULL
twice	NULL
purified	NULL
by	NULL
CsCl	NULL
banding	NULL
were	NULL
transfected	NULL
into	NULL
cells	NULL
by	NULL
electroporation	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
x	NULL
10Â°	NULL
cells	NULL
in	NULL
400	NULL
pl	NULL
of	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
were	NULL
electroporated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
40	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
at	NULL
960	NULL
F	NULL
and	NULL
280	NULL
V	NULL
(	NULL
CTLL-R8	NULL
)	NULL
or	NULL
300	NULL
V	NULL
(	NULL
EL-4	NULL
and	NULL
P815	NULL
)	NULL
,	NULL
in	NULL
a	NULL
4-mm-diameter	NULL
electroporation	NULL
cuvette	NULL
by	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
(	NULL
Richmond	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
electroporated	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
150-mm-diameter	NULL
petri	NULL
dishes	NULL
containing	NULL
prewarmed	NULL
media	NULL
and	NULL
incubated	NULL
for	NULL
48	NULL
h.	NULL
CAT	NULL
assay	NULL
.	NULL

CAT	NULL
activity	NULL
in	NULL
the	NULL
transfected	NULL
cells	NULL
was	NULL
tested	NULL
by	NULL
using	NULL
a	NULL
CAT	NULL
enzyme	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
Co.	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
for	NULL
CAT	NULL
assay	NULL
were	NULL
prepared	NULL
by	NULL
freezing	NULL
and	NULL
thawing	NULL
cells	NULL
three	NULL
times	NULL
in	NULL
150	NULL
pl	NULL
of	NULL
0.25	NULL
M	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
heated	NULL
at	NULL
60Â°C	NULL
for	NULL
10	NULL
min	NULL
to	NULL
inactivate	NULL
endogenous	NULL
acetylase	NULL
and	NULL
spun	NULL
for	NULL
10	NULL
min	NULL
to	NULL
remove	NULL
particulate	NULL
debris	NULL
.	NULL

The	NULL
level	NULL
of	NULL
CAT	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
CAT	NULL
plasmid	NULL
DNA	NULL
introduced	NULL
by	NULL
transfection	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
DNA	NULL
dot	NULL
blot	NULL
analysis	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
pl	NULL
of	NULL
cell	NULL
extract	NULL
was	NULL
sequentially	NULL
incubated	NULL
at	NULL
37Â°C	NULL
for	NULL
30	NULL
min	NULL
(	NULL
each	NULL
)	NULL
with	NULL
RNase	NULL
A	NULL
(	NULL
100	NULL
ug/ml	NULL
!	NULL
)	NULL

and	NULL
then	NULL
with	NULL
proteinase	NULL
K	NULL
(	NULL
100	NULL
pg/ml	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
2	NULL
volumes	NULL
of	NULL
20	NULL
%	NULL
SSC	NULL
(	NULL
1x	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
was	NULL
denatured	NULL
in	NULL
0.25	NULL
N	NULL
NaOH	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Samples	NULL
were	NULL
serially	NULL
diluted	NULL
on	NULL
prechilled	NULL
0.125	NULL
N	NULL
NaOH-0.125x	NULL
SSC	NULL
and	NULL
dotted	NULL
onto	NULL
GeneScreen	NULL
Plus	NULL
membranes	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Membranes	NULL
were	NULL
prehybridized	NULL
for	NULL
30	NULL
min	NULL
and	NULL
hybridized	NULL
to	NULL
*Â°P-labeled	NULL
pCAT	NULL
DNA	NULL
.	NULL

After	NULL
being	NULL
washed	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

The	NULL
volumes	NULL
of	NULL
the	NULL
cell	NULL
extracts	NULL
used	NULL
in	NULL
CAT	NULL
assay	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
transfected	NULL
CAT	NULL
DNA	NULL
,	NULL
determined	NULL
by	NULL
the	NULL
intensities	NULL
of	NULL
the	NULL
hybridization	NULL
signals	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
containing	NULL
the	NULL
normalized	NULL
volume	NULL
of	NULL
cell	NULL
extract	NULL
,	NULL
25	NULL
ug	NULL
of	NULL
n-butyryl	NULL
coenzyme	NULL
A	NULL
,	NULL
and	NULL
0.05	NULL
wCi	NULL
of	NULL
[	NULL
'*CJ	NULL
)	NULL
chloramphenicol	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
)	NULL
supplemented	NULL
with	NULL
0.25	NULL
M	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
125	NULL
pl	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
37Â°C	NULL
overnight	NULL
,	NULL
with	NULL
an	NULL
additional	NULL
25	NULL
ug	NULL
of	NULL
n-butyryl	NULL
coenzyme	NULL
A	NULL
added	NULL
at	NULL
2	NULL
to	NULL
4	NULL
h	NULL
after	NULL
the	NULL
initiation	NULL
of	NULL
the	NULL
reaction	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
acetylated	NULL
chloramphenicol	NULL
produced	NULL
was	NULL
determined	NULL
either	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
or	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
NEs	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
8	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
3	NULL
pelleted	NULL
cell	NULL
volumes	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N	NULL
'	NULL
-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothrei-tol	NULL
[	NULL
DTT	NULL
]	NULL
)	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
homogenized	NULL
with	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
(	NULL
10	NULL
strokes	NULL
,	NULL
type	NULL
B	NULL
pestle	NULL
)	NULL
,	NULL
and	NULL
centrifuged	NULL
at	NULL
1,000	NULL
x	NULL
g	NULL
to	NULL
sediment	NULL
the	NULL
nuclei	NULL
.	NULL

The	NULL
nucleus	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
a	NULL
0.5	NULL
packed-nuclei	NULL
volume	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
20	NULL
mM	NULL
KCl	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
25	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
glycerol	NULL
)	NULL
.	NULL

A	NULL
0.5	NULL
packed-nuclei	NULL
volume	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1.2	NULL
M	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
)	NULL
was	NULL
subsequently	NULL
added	NULL
drop	NULL
by	NULL
drop	NULL
with	NULL
constant	NULL
agitation	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
extracted	NULL
at	NULL
4Â°C	NULL
for	NULL
30	NULL
min	NULL
and	NULL
centrifuged	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
collected	NULL
was	NULL
dialyzed	NULL
against	NULL
50	NULL
volumes	NULL
of	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
6692	NULL
KOIZUMI	NULL
ET	NULL
AL	NULL
.	NULL

7.9	NULL
]	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mM	NULL
PMSF	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
)	NULL
for	NULL
1	NULL
h	NULL
and	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
NEs	NULL
thus	NULL
prepared	NULL
were	NULL
stored	NULL
at	NULL
-70Â°C	NULL
until	NULL
use	NULL
.	NULL

NE	NULL
of	NULL
HeLa	NULL
cells	NULL
was	NULL
obtained	NULL
from	NULL
Stratagene	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
6	NULL
)	NULL
with	NULL
a	NULL
Bio-Rad	NULL
assay	NULL
kit	NULL
.	NULL

An	NULL
Ncol-KpnI	NULL
fragment	NULL
of	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
Pfp	NULL
(	NULL
residues	NULL
-609	NULL
through	NULL
-491	NULL
)	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
Â«	NULL
-	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
by	NULL
using	NULL
Klenow	NULL
fragment	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
JATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
purified	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
.	NULL

A	NULL
typical	NULL
binding	NULL
reaction	NULL
mixture	NULL
(	NULL
25-pl	NULL
final	NULL
volume	NULL
)	NULL
consisted	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
NE	NULL
,	NULL
2	NULL
x	NULL
10Â°	NULL
cpm	NULL
of	NULL
end-labeled	NULL
probe	NULL
(	NULL
0.2	NULL
to	NULL
0.5	NULL
ng	NULL
)	NULL
,	NULL
2.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
,	NULL
Piscat-away	NULL
,	NULL
N.J.	NULL
)	NULL
,	NULL
25	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
6.25	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
20	NULL
min	NULL
at	NULL
0Â°C	NULL
,	NULL
the	NULL
resulting	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
from	NULL
the	NULL
free	NULL
probe	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
6	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
.	NULL

The	NULL
coding-strand	NULL
sequences	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
(	NULL
overlapping	NULL
oligonucleotides	NULL
,	NULL
OL	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
Fig	NULL
.	NULL

4A	NULL
(	NULL
multiple-base	NULL
mutations	NULL
,	NULL
M1	NULL
to	NULL
4	NULL
)	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

4B	NULL
(	NULL
one-point	NULL
mutations	NULL
,	NULL
OP	NULL
1	NULL
to	NULL
10	NULL
)	NULL
.	NULL

Mutations	NULL
were	NULL
designed	NULL
to	NULL
substitute	NULL
purines	NULL
with	NULL
the	NULL
nonpairing	NULL
pyrimidine	NULL
residues	NULL
and	NULL
vice	NULL
versa	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
Ets-1	NULL
binding	NULL
site	NULL
was	NULL
synthesized	NULL
as	NULL
a	NULL
32-mer	NULL
(	NULL
5-TTCCAGAGGATGTGGCTTCTGCGGGAG	NULL
AGCTT	NULL
)	NULL
derived	NULL
from	NULL
the	NULL
reported	NULL
sequence	NULL
(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
the	NULL
30-bp	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-AT	NULL
binding	NULL
site	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
A.	NULL
Granelli-Piperno	NULL
(	NULL
The	NULL
Rockefeller	NULL
University	NULL
)	NULL
(	NULL
12	NULL
)	NULL
.	NULL

UV	NULL
cross-linking	NULL
experiment	NULL
.	NULL

In	NULL
situ	NULL
UV	NULL
cross-linking	NULL
of	NULL
DNA-protein	NULL
with	NULL
end-labeled	NULL
OL	NULL
2	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
established	NULL
procedure	NULL
(	NULL
30	NULL
)	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

After	NULL
resolution	NULL
by	NULL
EMSA	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
subjected	NULL
to	NULL
autoradiog-raphy	NULL
briefly	NULL
to	NULL
locate	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

The	NULL
areas	NULL
identified	NULL
were	NULL
excised	NULL
,	NULL
pooled	NULL
in	NULL
35-mm-diameter	NULL
petri	NULL
dishes	NULL
,	NULL
and	NULL
irradiated	NULL
with	NULL
UV	NULL
for	NULL
1	NULL
h.	NULL
Alternatively	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
first	NULL
subjected	NULL
to	NULL
UV	NULL
irradiation	NULL
(	NULL
2,500	NULL
mJ	NULL
)	NULL
by	NULL
using	NULL
a	NULL
Stratalinker	NULL
(	NULL
Stratagene	NULL
)	NULL
,	NULL
and	NULL
the	NULL
areas	NULL
containing	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
located	NULL
by	NULL
autoradiogra-phy	NULL
and	NULL
excised	NULL
.	NULL

The	NULL
cross-linked	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
then	NULL
collected	NULL
by	NULL
either	NULL
electroelution	NULL
or	NULL
passive	NULL
diffusion	NULL
into	NULL
the	NULL
soaking	NULL
buffer	NULL
,	NULL
boiled	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-containing	NULL
loading	NULL
buffer	NULL
,	NULL
and	NULL
resolved	NULL
by	NULL
SDS-10	NULL
or	NULL
6	NULL
%	NULL
PAGE	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
under	NULL
vacuum	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

Controls	NULL
for	NULL
this	NULL
type	NULL
of	NULL
experiment	NULL
included	NULL
SDS-PAGE	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
eluted	NULL
from	NULL
a	NULL
nonspecific	NULL
band	NULL
on	NULL
EMSA	NULL
following	NULL
UV	NULL
cross-linking	NULL
or	NULL
of	NULL
the	NULL
complexes	NULL
without	NULL
being	NULL
cross-linked	NULL
by	NULL
UV	NULL
irradiation	NULL
prior	NULL
to	NULL
SDS-PAGE	NULL
.	NULL

RESULTS	NULL
Functional	NULL
mapping	NULL
of	NULL
the	NULL
mouse	NULL
Pfp	NULL
promoter	NULL
and	NULL
regulatory	NULL
regions	NULL
.	NULL

Although	NULL
several	NULL
potential	NULL
regulatory	NULL
elements	NULL
in	NULL
mouse	NULL
Pfp	NULL
have	NULL
been	NULL
identified	NULL
by	NULL
sequence	NULL
comparison	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
functional	NULL
relevances	NULL
of	NULL
these	NULL
elements	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
established	NULL
.	NULL

Recently	NULL
,	NULL
several	NULL
groups	NULL
,	NULL
including	NULL
ours	NULL
,	NULL
have	NULL
attempted	NULL
to	NULL
address	NULL
this	NULL
issue	NULL
(	NULL
22	NULL
,	NULL
40	NULL
)	NULL
.	NULL

To	NULL
locate	NULL
the	NULL
promoter	NULL
region	NULL
that	NULL
potentially	NULL
regulates	NULL
Pfp	NULL
expression	NULL
,	NULL
we	NULL
have	NULL
constructed	NULL
a	NULL
series	NULL
of	NULL
plasmids	NULL
that	NULL
contain	NULL
5	NULL
'	NULL
sequential	NULL
deletions	NULL
of	NULL
mouse	NULL
Pfp	NULL
5'-flanking	NULL
region	NULL
fused	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

Since	NULL
reporter	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

UV	NULL
TATA	NULL
A	NULL
NF-kB	NULL
-	NULL
CRE	NULL
Y-INF	NULL
AP-2	NULL
AP-	NULL
NIP	NULL
CRE	NULL
AP-2	NULL
ICC	NULL
!	NULL

+	NULL
U	NULL
+	NULL
U	NULL
|	NULL
Read	NULL
i-	NULL
#	NULL
t-4-=	NULL
=	NULL
=-	NULL
==	NULL
>	NULL
+	NULL
--	NULL
+	NULL
-/-1827	NULL
~1200	NULL
-1000	NULL
+800	NULL
400	NULL
+200	NULL
+1	NULL
+536	NULL
EcoRI	NULL
EcoRI	NULL
f	NULL
--	NULL
-	NULL
_-	NULL
Â«	NULL
09	NULL
522	NULL
491	NULL
Neot	NULL
Poull	NULL
KpnI	NULL
B	NULL
400	NULL
[	NULL
-	NULL
]	NULL
cticns	NULL
300	NULL
4	NULL
a	NULL
HH	NULL
rss	NULL
L	NULL
T	NULL
BBs	NULL
cla	NULL
T	NULL
~	NULL
â¬	NULL
2	NULL
60-o	NULL
<	NULL
lâ	NULL
<	NULL
O	NULL
$	NULL
so-ic	NULL
|	NULL
_-	NULL
B	NULL
nsd	NULL
i	NULL
E	NULL
Co	NULL
'	NULL
(	NULL
B	NULL
I	NULL
by	NULL
#	NULL
b	NULL
t	NULL
PR	NULL
Pst	NULL
0	NULL
Bd	NULL
Bs	NULL
Bst	NULL
PS	NULL
142	NULL
-	NULL
-316	NULL
+62	NULL
-	NULL
-566	NULL
+62	NULL
-	NULL
-670	NULL
+62	NULL
-	NULL
-700	NULL
+62	NULL
-	NULL
141	NULL
+62	NULL
-	NULL
411	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Sequence	NULL
comparison	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
mouse	NULL
Pfp	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Alignment	NULL
of	NULL
the	NULL
potential	NULL
regulatory	NULL
elements	NULL
identified	NULL
by	NULL
computer-assisted	NULL
sequence	NULL
com-parison	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CTLL-R8	NULL
,	NULL
EL-4	NULL
,	NULL
and	NULL
P815	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
pCAT	NULL
reporter	NULL
construct	NULL
.	NULL

To	NULL
adjust	NULL
for	NULL
the	NULL
different	NULL
transfection	NULL
efficiencies	NULL
,	NULL
volumes	NULL
of	NULL
cell	NULL
extracts	NULL
containing	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
plasmid	NULL
DNA	NULL
as	NULL
determined	NULL
by	NULL
dot	NULL
blot	NULL
analysis	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
were	NULL
used	NULL
for	NULL
CAT	NULL
assays	NULL
.	NULL

The	NULL
CAT	NULL
activities	NULL
were	NULL
determined	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
and	NULL
normalized	NULL
against	NULL
the	NULL
activity	NULL
obtained	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
pSVCAT	NULL
vector	NULL
,	NULL
which	NULL
usually	NULL
gave	NULL
no	NULL
or	NULL
low	NULL
counts	NULL
.	NULL

The	NULL
result	NULL
for	NULL
each	NULL
construct	NULL
was	NULL
derived	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

constructs	NULL
prepared	NULL
in	NULL
a	NULL
plasmid	NULL
vector	NULL
which	NULL
contains	NULL
the	NULL
CAT	NULL
gene	NULL
alone	NULL
drove	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
only	NULL
weakly	NULL
,	NULL
we	NULL
generated	NULL
constructs	NULL
with	NULL
similar	NULL
5'-flanking	NULL
sequences	NULL
cloned	NULL
into	NULL
a	NULL
plasmid	NULL
vector	NULL
containing	NULL
the	NULL
CAT	NULL
gene	NULL
and	NULL
the	NULL
early	NULL
promoter	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
in	NULL
order	NULL
to	NULL
potentiate	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Pfp	NULL
sequences	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
transiently	NULL
expressed	NULL
in	NULL
both	NULL
CTLs	NULL
and	NULL
non-CTLs	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
CAT	NULL
expression	NULL
were	NULL
normalized	NULL
against	NULL
the	NULL
expression	NULL
driven	NULL
by	NULL
the	NULL
simian	NULL
virus	NULL
40-CAT	NULL
vector	NULL
.	NULL

Although	NULL
the	NULL
region	NULL
encompassing	NULL
nucleotides	NULL
+62	NULL
through	NULL
-141	NULL
(	NULL
transcription	NULL
initiation	NULL
site	NULL
as	NULL
+1	NULL
)	NULL
was	NULL
able	NULL
to	NULL
drive	NULL
the	NULL
expression	NULL
of	NULL
CAT	NULL
in	NULL
CTLL-R8	NULL
,	NULL
EL-4	NULL
,	NULL
and	NULL
P815	NULL
cells	NULL
,	NULL
a	NULL
much	NULL
higher	NULL
efficiency	NULL
was	NULL
observed	NULL
in	NULL
CTLL-R8	NULL
(	NULL
47-fold	NULL
)	NULL
than	NULL
in	NULL
nonkiller	NULL
cells	NULL
(	NULL
4-fold	NULL
for	NULL
EL-4	NULL
and	NULL
6-fold	NULL
for	NULL
P815	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
a	NULL
basal	NULL
promoter	NULL
activity	NULL
for	NULL
Pfp	NULL
is	NULL
present	NULL
within	NULL
this	NULL
region	NULL
.	NULL

Incorporation	NULL
of	NULL
the	NULL
sequence	NULL
between	NULL
residues	NULL
-142	NULL
through	NULL
-411	NULL
into	NULL
the	NULL
construct	NULL
failed	NULL
to	NULL
drive	NULL
more	NULL
CAT	NULL
expression	NULL
(	NULL
com-paring	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
i	NULL
,	NULL
-i41	NULL
and	NULL
pCAT	NULL
is	NULL
:	NULL
..	NULL
-411	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
region	NULL
does	NULL
not	NULL
contain	NULL
strong	NULL
regulatory	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

No-tably	NULL
,	NULL
a	NULL
construct	NULL
(	NULL
pCAT_14	NULL
;	NULL
i	NULL
,	NULL
-316	NULL
)	NULL
lacking	NULL
the	NULL
sequence	NULL
encompassing	NULL
residues	NULL
+62	NULL
through	NULL
-141	NULL
lost	NULL
its	NULL
ability	NULL
to	NULL
drive	NULL
the	NULL
CAT	NULL
expression	NULL
,	NULL
indicating	NULL
again	NULL
that	NULL
the	NULL
essential	NULL
promoter	NULL
activity	NULL
for	NULL
Pfp	NULL
resides	NULL
within	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
up	NULL
to	NULL
residue	NULL
-141	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
Inclusion	NULL
of	NULL
sequence	NULL
extending	NULL
to	NULL
residue	NULL
-566	NULL
in	NULL
the	NULL
reporter	NULL
construct	NULL
enhanced	NULL
CAT	NULL
expression	NULL
profoundly	NULL
in	NULL
CTLL-R8	NULL
but	NULL
only	NULL
slightly	NULL
in	NULL
EL-4	NULL
and	NULL
P815	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Further	NULL
extension	NULL
of	NULL
the	NULL
Pfp	NULL
5'-flanking	NULL
sequence	NULL
to	NULL
residue	NULL
-670	NULL
and	NULL
residue	NULL
-700	NULL
,	NULL
however	NULL
,	NULL
reduced	NULL
the	NULL
CAT	NULL
gene	NULL
expression	NULL
in	NULL
all	NULL
three	NULL
cell	NULL
types	NULL
examined	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
a	NULL
killer	NULL
cell-specific	NULL
positive	NULL
regulatory	NULL
ele-ment	NULL
(	NULL
s	NULL
)	NULL
is	NULL
present	NULL
between	NULL
residue	NULL
-412	NULL
and	NULL
-566	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
further	NULL
characterize	NULL
this	NULL
region	NULL
.	NULL

DNA-protein	NULL
interactions	NULL
in	NULL
the	NULL
Ncol-KprI	NULL
region	NULL
(	NULL
residues	NULL
-609	NULL
through	NULL
-491	NULL
)	NULL
of	NULL
mouse	NULL
Pfp	NULL
.	NULL

Since	NULL
DNA-binding	NULL
proteins	NULL
may	NULL
represent	NULL
frams-acting	NULL
factors	NULL
that	NULL
affect	NULL
the	NULL
transcription	NULL
of	NULL
Pfp	NULL
,	NULL
we	NULL
first	NULL
set	NULL
out	NULL
to	NULL
identify	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
-566	NULL
to	NULL
-412	NULL
sequence	NULL
.	NULL

To	NULL
circumvent	NULL
the	NULL
limitation	NULL
of	NULL
available	NULL
restriction	NULL
sites	NULL
surrounding	NULL
this	NULL
region	NULL
,	NULL
we	NULL
initially	NULL
used	NULL
a	NULL
119-bp	NULL
Ncol-KpnI	NULL
fragment	NULL
(	NULL
residues	NULL
-609	NULL
through	NULL
-491	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
EMSA	NULL
to	NULL
examine	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
region	NULL
of	NULL
interest	NULL
.	NULL

Comparing	NULL
the	NULL
electrophoretic	NULL
profile	NULL
of	NULL
unstimulated	NULL
CTLL-R8	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
with	NULL
that	NULL
of	NULL
the	NULL
CTLL-RS8	NULL
stimulated	NULL
with	NULL
conditioned	NULL
medium	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
ConA	NULL
and	NULL
PMA	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
it	NULL
was	NULL
noted	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
a	NULL
DNA-protein	NULL
complex	NULL
(	NULL
designated	NULL
B1	NULL
)	NULL
was	NULL
reduced	NULL
,	NULL
and	NULL
concomitantly	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
another	NULL
complex	NULL
(	NULL
designated	NULL
B2	NULL
)	NULL
was	NULL
reciprocally	NULL
induced	NULL
in	NULL
the	NULL
stimulated	NULL
cells	NULL
.	NULL

This	NULL
phenomenon	NULL
was	NULL
also	NULL
observed	NULL
for	NULL
primary	NULL
killer	NULL
cells	NULL
.	NULL

The	NULL
electrophoretic	NULL
profile	NULL
of	NULL
adherent	NULL
LAK	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
derived	NULL
from	NULL
IL-2-stimulated	NULL
splenic	NULL
T	NULL
lymphocytes	NULL
(	NULL
15	NULL
,	NULL
49	NULL
)	NULL
,	NULL
showed	NULL
a	NULL
strong	NULL
B2	NULL
band	NULL
and	NULL
a	NULL
faint	NULL
B1	NULL
band	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
that	NULL
of	NULL
the	NULL
unstimulated	NULL
splenic	NULL
T	NULL
cells	NULL
displayed	NULL
only	NULL
the	NULL
B1	NULL
band	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
electrophoretic	NULL
profile	NULL
of	NULL
confluent	NULL
resting	NULL
CTLL-R8	NULL
cells	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
exhibited	NULL
an	NULL
intermediate	NULL
pattern	NULL
,	NULL
with	NULL
the	NULL
B1	NULL
and	NULL
B2	NULL
bands	NULL
equally	NULL
present	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

B1	NULL
and	NULL
B2	NULL
bands	NULL
were	NULL
also	NULL
observed	NULL
in	NULL
the	NULL
electrophoretic	NULL
profile	NULL
of	NULL
another	NULL
CTL	NULL
line	NULL
,	NULL
CTLL-2	NULL
,	NULL
maintained	NULL
in	NULL
conditioned	NULL
medium	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
third	NULL
DNA-protein	NULL
complex	NULL
,	NULL
located	NULL
below	NULL
the	NULL
B2	NULL
band	NULL
and	NULL
present	NULL
at	NULL
variable	NULL
intensities	NULL
in	NULL
different	NULL
cells	NULL
,	NULL
was	NULL
not	NULL
further	NULL
investigated	NULL
since	NULL
it	NULL
was	NULL
not	NULL
modulated	NULL
by	NULL
the	NULL
T-cell	NULL
activators	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Another	NULL
DNA	NULL
fragment	NULL
,	NULL
KpnI-HinPI	NULL
(	NULL
residues	NULL
-490	NULL
through	NULL
-263	NULL
)	NULL
,	NULL
was	NULL
similarly	NULL
tested	NULL
in	NULL
the	NULL
binding	NULL
assay	NULL
to	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
targeted	NULL
region	NULL
(	NULL
residues	NULL
-566	NULL
through	NULL
-412	NULL
)	NULL
.	NULL

However	NULL
,	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
by	NULL
this	NULL
probe	NULL
displayed	NULL
similar	NULL
electrophoretic	NULL
patterns	NULL
in	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
CTLL-R8	NULL
cells	NULL
(	NULL
{	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
B1-B2	NULL
modulation	NULL
observed	NULL
with	NULL
the	NULL
Ncol-KprI	NULL
fragment	NULL
may	NULL
solely	NULL
account	NULL
for	NULL
the	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
sequence	NULL
between	NULL
residues	NULL
-412	NULL
and	NULL
-566	NULL
in	NULL
CTLL-R8	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
cell-type	NULL
specificity	NULL
of	NULL
B1	NULL
and	NULL
B2	NULL
formation	NULL
,	NULL
we	NULL
have	NULL
also	NULL
tested	NULL
nonlymphoid	NULL
cells	NULL
(	NULL
primary	NULL
hepato-cytes	NULL
,	NULL
P815	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
[	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
,	NULL
and	NULL
not	NULL
shown	NULL
,	NULL
respectively	NULL
]	NULL
)	NULL
and	NULL
nonkiller	NULL
T	NULL
lymphocytes	NULL
(	NULL
YAC-1	NULL
and	NULL
EL-4	NULL
[	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
to	NULL
12	NULL
,	NULL
respectively	NULL
]	NULL
)	NULL
in	NULL
EMSA	NULL
by	NULL
using	NULL
the	NULL
Ncol-KpnI	NULL
probe	NULL
.	NULL

B1	NULL
was	NULL
found	NULL
to	NULL
be	NULL
ubiquitously	NULL
present	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
tested	NULL
.	NULL

B2	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
killer	NULL
cell	NULL
specific	NULL
,	NULL
since	NULL
it	NULL
was	NULL
not	NULL
present	NULL
in	NULL
EL-4	NULL
cells	NULL
stimulated	NULL
with	NULL
conditioned	NULL
medium	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
ConA	NULL
and	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
13	NULL
,	NULL
respectively	NULL
,	NULL
compared	NULL
with	NULL
unstimulated	NULL
EL-4	NULL
cells	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
stimuli	NULL
failed	NULL
to	NULL
reduce	NULL
Bl	NULL
in	NULL
EL-4	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
a	NULL
human	NULL
non-CTL	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
stimulated	NULL
with	NULL
phytohemagglutinin	NULL
and	NULL
PMA	NULL
(	NULL
12	NULL
)	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
occurrence	NULL
of	NULL
the	NULL
B1-B2	NULL
modu-	NULL
KILLER	NULL
CELL-SPECIFIC	NULL
REGULATORY	NULL
ELEMENT	NULL
OF	NULL
MOUSE	NULL
Pfp	NULL
6693	NULL
A	NULL
CTLL-R8	NULL
liver	NULL
cells	NULL
P815	NULL
YAC-1	NULL
12Â°03	NULL
,	NULL
4	NULL
-	NULL
5	NULL
mo	NULL
-f	NULL
geo-	NULL
10	NULL
'M	NULL
12	NULL
13	NULL
Ncol-Kpnl	NULL
control	NULL
DNA	NULL
B	NULL
C	NULL
o	NULL
1T	NULL
?	NULL

|	NULL
o	NULL
\	NULL
\p	NULL
O	NULL
-	NULL
1Â°	NULL
_	NULL
>	NULL
x	NULL
51	NULL
-	NULL
lead	NULL
bas	NULL
ba	NULL
p	NULL
>	NULL
-	NULL
lied	NULL
b-	NULL
bs	NULL
los	NULL
5	NULL
ig	NULL
imepaang	NULL
say	NULL
:	NULL
ane	NULL
.	NULL

|	NULL
<	NULL
9	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
Ncol-KpnI	NULL
(	NULL
residues	NULL
-609	NULL
to	NULL
-491	NULL
)	NULL
region	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cell	NULL
type	NULL
distribution	NULL
of	NULL
B1	NULL
and	NULL
B2	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
NE	NULL
was	NULL
incubated	NULL
with	NULL
an	NULL
probe	NULL
(	NULL
0.2	NULL
ng	NULL
,	NULL
2	NULL
x	NULL
10Â°	NULL
cpm	NULL
)	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
unstimulated	NULL
CTLL-R8	NULL
;	NULL
2	NULL
,	NULL
conditioned	NULL
medium	NULL
(	NULL
CM	NULL
)	NULL
-stimulated	NULL
CTLL-R8	NULL
;	NULL
3	NULL
,	NULL
IL-2-stimulated	NULL
CTLL-R8	NULL
;	NULL
4	NULL
,	NULL
ConA-	NULL
and	NULL
PMA	NULL
(	NULL
C/P	NULL
)	NULL
-stimulated	NULL
CTLL-R8	NULL
;	NULL
5	NULL
,	NULL
resting	NULL
(	NULL
rest	NULL
.	NULL
)	NULL

CTLL-R8	NULL
;	NULL
6	NULL
,	NULL
adherent	NULL
LAK	NULL
(	NULL
A-LAK	NULL
)	NULL
cells	NULL
;	NULL
7	NULL
,	NULL
liver	NULL
cells	NULL
;	NULL
8	NULL
,	NULL
P815	NULL
;	NULL
9	NULL
,	NULL
YAC-1	NULL
;	NULL
10	NULL
,	NULL
unstimulated	NULL
EL-4	NULL
;	NULL
11	NULL
,	NULL
conditioned	NULL
medium-stimulated	NULL
EL-4	NULL
;	NULL
12	NULL
,	NULL
IL-2-stimulated	NULL
EL-4	NULL
;	NULL
13	NULL
,	NULL
ConA-	NULL
and	NULL
PMA-stimulated	NULL
EL-4	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sequence	NULL
specificity	NULL
of	NULL
B1	NULL
and	NULL
B2	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
no	NULL
competitor	NULL
;	NULL
2	NULL
to	NULL
5	NULL
,	NULL
20-	NULL
,	NULL
40-	NULL
,	NULL
80-	NULL
,	NULL
and	NULL
160-fold	NULL
molar	NULL
excess	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
unlabeled	NULL
Ncol-KpnI	NULL
fragment	NULL
(	NULL
119	NULL
bp	NULL
)	NULL
;	NULL
6	NULL
to	NULL
9	NULL
,	NULL
20-	NULL
,	NULL
40-	NULL
,	NULL
80-	NULL
,	NULL
and	NULL
160-fold	NULL
molar	NULL
excess	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
an	NULL
unrelated	NULL
competitor	NULL
derived	NULL
from	NULL
pBluescript	NULL
SK+	NULL
(	NULL
Pvull-Kpnl	NULL
,	NULL
129	NULL
bp	NULL
[	NULL
Stratagene	NULL
]	NULL
)	NULL
.	NULL

NE	NULL
of	NULL
resting	NULL
CTLL-R8	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
media	NULL
.	NULL

lation	NULL
appeared	NULL
to	NULL
be	NULL
restricted	NULL
to	NULL
activated	NULL
killer	NULL
cells	NULL
,	NULL
suggesting	NULL
its	NULL
involvement	NULL
in	NULL
regulating	NULL
the	NULL
transcription	NULL
of	NULL
Pfp	NULL
in	NULL
a	NULL
cell-type-specific	NULL
manner	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
sequence	NULL
specificity	NULL
of	NULL
B1	NULL
and	NULL
B2	NULL
complexes	NULL
,	NULL
the	NULL
Ncol-KpnI	NULL
fragment	NULL
and	NULL
a	NULL
similar-length	NULL
fragment	NULL
were	NULL
used	NULL
in	NULL
a	NULL
binding	NULL
competition	NULL
assay	NULL
.	NULL

Both	NULL
complexes	NULL
were	NULL
specifically	NULL
inhibited	NULL
by	NULL
the	NULL
Ncol-KpnI	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
but	NULL
not	NULL
by	NULL
the	NULL
control	NULL
6694	NULL
KOIZUMI	NULL
ET	NULL
AL	NULL
.	NULL

OL	NULL
1	NULL
OL	NULL
2	NULL
OL	NULL
3	NULL
TGGGATGTAGGTATGGACA	NULL
CTGGGATGTAGGTATGGACAGGAAGTGGGTAC	NULL
GGTATGGACAGGAAGTGGGTACCAGCTTTGAC	NULL
-4	NULL
Ã©	NULL
1	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Localization	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Competition	NULL
of	NULL
complexes	NULL
by	NULL
DNA	NULL
fragments	NULL
and	NULL
overlapping	NULL
oligonucleotides	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
mixtures	NULL
contained	NULL
the	NULL
Ncol-KpnI	NULL
probe	NULL
(	NULL
0.2	NULL
ng	NULL
,	NULL
2	NULL
x	NULL
10Â°	NULL
cpm	NULL
)	NULL
,	NULL
5	NULL
pg	NULL
of	NULL
NE	NULL
of	NULL
resting	NULL
CTLL-R8	NULL
cells	NULL
,	NULL
and	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
each	NULL
of	NULL
the	NULL
following	NULL
competitors	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
no	NULL
competitor	NULL
;	NULL
2	NULL
,	NULL
Ncol-KpnI	NULL
(	NULL
N-K	NULL
;	NULL
residues	NULL
-609	NULL
to	NULL
-491	NULL
,	NULL
119	NULL
bp	NULL
)	NULL
;	NULL
3	NULL
,	NULL
control	NULL
DNA	NULL
,	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
;	NULL
4	NULL
,	NULL
Ncol-Pvull	NULL
,	NULL
(	NULL
N-P	NULL
;	NULL
residues	NULL
-609	NULL
to	NULL
-523	NULL
,	NULL
87	NULL
bp	NULL
)	NULL
;	NULL
5	NULL
,	NULL
Pvull-KpnI	NULL
(	NULL
P-K	NULL
;	NULL
residues	NULL
-522	NULL
to	NULL
-491	NULL
,	NULL
32	NULL
bp	NULL
)	NULL
;	NULL
6	NULL
,	NULL
OL	NULL
1	NULL
(	NULL
residues	NULL
-532	NULL
to	NULL
-503	NULL
,	NULL
30	NULL
bp	NULL
)	NULL
;	NULL
7	NULL
,	NULL
OL	NULL
2	NULL
(	NULL
residues	NULL
-522	NULL
to	NULL
-491	NULL
,	NULL
32	NULL
bp	NULL
)	NULL
;	NULL
8	NULL
,	NULL
OL	NULL
3	NULL
(	NULL
residues	NULL
-512	NULL
to	NULL
-481	NULL
,	NULL
32	NULL
b2p	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Direct	NULL
binding	NULL
assay	NULL
with	NULL
overlapping	NULL
oligonucleotides	NULL
.	NULL

*P	NULL
-labeled	NULL
oligonucleotide	NULL
(	NULL
2	NULL
x	NULL
10Â°	NULL
cpm	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
NE	NULL
of	NULL
resting	NULL
CTLL-R8	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Lanes	NULL
1	NULL
to	NULL
3	NULL
,	NULL
OL	NULL
1	NULL
to	NULL
3	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Alignment	NULL
and	NULL
sequences	NULL
of	NULL
the	NULL
overlapping	NULL
oligonucleotides	NULL
.	NULL

Note	NULL
that	NULL
OL	NULL
2	NULL
represents	NULL
the	NULL
Pvull-KpnI	NULL
(	NULL
residues	NULL
-522	NULL
to	NULL
-491	NULL
)	NULL
region	NULL
.	NULL

Underlines	NULL
denote	NULL
the	NULL
12-bp	NULL
region	NULL
containing	NULL
the	NULL
putative	NULL
protein-binding	NULL
sites	NULL
(	NULL
see	NULL
text	NULL
)	NULL
.	NULL

fragment	NULL
,	NULL
even	NULL
at	NULL
the	NULL
highest	NULL
concentration	NULL
tested	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
.	NULL

In	NULL
the	NULL
following	NULL
,	NULL
the	NULL
nuclear	NULL
factors	NULL
that	NULL
form	NULL
the	NULL
ubiquitous	NULL
B1	NULL
and	NULL
the	NULL
killer	NULL
cell-specific	NULL
B2	NULL
will	NULL
be	NULL
referred	NULL
to	NULL
as	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
,	NULL
respectively	NULL
.	NULL

Localization	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

To	NULL
localize	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
,	NULL
the	NULL
Ncol-KpnI	NULL
fragment	NULL
(	NULL
residues	NULL
-609	NULL
through	NULL
-491	NULL
)	NULL
was	NULL
digested	NULL
with	NULL
Pvull	NULL
to	NULL
generate	NULL
two	NULL
smaller	NULL
fragments	NULL
for	NULL
use	NULL
in	NULL
the	NULL
binding	NULL
competition	NULL
assay	NULL
.	NULL

The	NULL
Pvull-KpnI	NULL
fragment	NULL
(	NULL
residues	NULL
-522	NULL
through	NULL
-491	NULL
)	NULL
was	NULL
able	NULL
to	NULL
inhibit	NULL
both	NULL
the	NULL
B1	NULL
and	NULL
the	NULL
B2	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
as	NULL
effectively	NULL
as	NULL
the	NULL
intact	NULL
Ncol-KpnI	NULL
fragment	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
NcoI-Pvull	NULL
fragment	NULL
(	NULL
residues	NULL
-609	NULL
through	NULL
-523	NULL
)	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
displayed	NULL
no	NULL
such	NULL
effect	NULL
at	NULL
all	NULL
.	NULL

These	NULL
results	NULL
revealed	NULL
that	NULL
the	NULL
protein-binding	NULL
sites	NULL
for	NULL
both	NULL
factors	NULL
reside	NULL
within	NULL
the	NULL
32-bp	NULL
Pvull-KpnI	NULL
fragment	NULL
.	NULL

Overlapping	NULL
oligonucleotides	NULL
(	NULL
OL	NULL
1	NULL
to	NULL
3	NULL
[	NULL
Fig	NULL
.	NULL

3C	NULL
]	NULL
)	NULL
,	NULL
of	NULL
which	NULL
OL	NULL
2	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
Pvull-KpnI	NULL
region	NULL
,	NULL
were	NULL
then	NULL
used	NULL
in	NULL
the	NULL
competition	NULL
assay	NULL
to	NULL
define	NULL
further	NULL
the	NULL
sites	NULL
involved	NULL
in	NULL
DNA-protein	NULL
interaction	NULL
.	NULL

Both	NULL
complexes	NULL
were	NULL
specifically	NULL
inhibited	NULL
by	NULL
OL	NULL
2	NULL
and	NULL
OL	NULL
3	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
but	NULL
not	NULL
by	NULL
OL	NULL
1	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Direct	NULL
binding	NULL
assay	NULL
also	NULL
showed	NULL
that	NULL
OL	NULL
1	NULL
could	NULL
not	NULL
form	NULL
B1	NULL
and	NULL
B2	NULL
complexes	NULL
,	NULL
whereas	NULL
both	NULL
OL	NULL
2	NULL
and	NULL
OL	NULL
3	NULL
did	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

A	NULL
Ale	NULL
ts	NULL
I	NULL
Es	NULL
3	NULL
a	NULL
2	NULL
p-â5	NULL
?	NULL

2	NULL
S	NULL
-491	NULL
WT	NULL
CTGGGA	NULL
TGTAGGT	NULL
ATGGACA	NULL
GGAAGT	NULL
GGGTAC	NULL
M1	NULL
=	NULL
--	NULL
--	NULL
--	NULL
GTGCTRG	NULL
--	NULL
--	NULL
--	NULL
-	NULL
______	NULL
______	NULL
M2	NULL
--	NULL
--	NULL
--	NULL
-______-	NULL
CGTTCAG	NULL
--	NULL
-	NULL
...	NULL
._____	NULL
M3	NULL
|	NULL
--	NULL
--	NULL
--	NULL
cccccc_	NULL
ccccce	NULL
,	NULL
TTCCTG	NULL
--	NULL
--	NULL
--	NULL
M4	NULL
=	NULL
--	NULL
--	NULL
--	NULL
eccccce	NULL
TTTGCA	NULL
B	NULL
R	NULL
=	NULL
o	NULL
&	NULL
=	NULL
in	NULL
w	NULL
mn	NULL
co	NULL
o	NULL
=	NULL
uz	NULL
8	NULL
o	NULL
$	NULL
56	NULL
s	NULL
(	NULL
85	NULL
Â»	NULL
``	NULL
5g	NULL
g	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
protein-binding	NULL
sequence	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Upper	NULL
panel	NULL
:	NULL
competition	NULL
assay	NULL
with	NULL
multiple-base	NULL
mutated	NULL
oligonucleotides	NULL
(	NULL
M1	NULL
to	NULL
4	NULL
)	NULL
.	NULL

End-labeled	NULL
OL	NULL
2	NULL
was	NULL
incubated	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
NE	NULL
of	NULL
resting	NULL
CTLL-R8	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
competitor	NULL
(	NULL
-	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
wild-type	NULL
OL	NULL
2	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
M	NULL
1	NULL
to	NULL
4	NULL
.	NULL

Lower	NULL
panel	NULL
:	NULL
nucleotide	NULL
sequences	NULL
of	NULL
M	NULL
1	NULL
to	NULL
4	NULL
.	NULL

The	NULL
sequences	NULL
are	NULL
aligned	NULL
with	NULL
the	NULL
wild-type	NULL
OL	NULL
2	NULL
,	NULL
and	NULL
identical	NULL
bases	NULL
are	NULL
denoted	NULL
by	NULL
dashes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Upper	NULL
panel	NULL
:	NULL
competition	NULL
assay	NULL
with	NULL
one-point	NULL
mutated	NULL
oligonucleotides	NULL
(	NULL
OP	NULL
1	NULL
to	NULL
10	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
performed	NULL
exactly	NULL
the	NULL
same	NULL
as	NULL
for	NULL
panel	NULL
A	NULL
,	NULL
except	NULL
for	NULL
the	NULL
use	NULL
of	NULL
OP	NULL
1	NULL
to	NULL
10	NULL
.	NULL

Lower	NULL
panel	NULL
:	NULL
location	NULL
of	NULL
the	NULL
nucleotide	NULL
substituted	NULL
in	NULL
OP	NULL
1	NULL
to	NULL
10	NULL
.	NULL

OP	NULL
1	NULL
to	NULL
5	NULL
and	NULL
OP	NULL
8	NULL
to	NULL
10	NULL
contain	NULL
mutations	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
the	NULL
putative	NULL
core	NULL
sequence	NULL
GGAAGT	NULL
.	NULL

OP	NULL
6	NULL
and	NULL
7	NULL
are	NULL
mutants	NULL
of	NULL
the	NULL
core	NULL
sequence	NULL
(	NULL
see	NULL
text	NULL
)	NULL
.	NULL

identical	NULL
behaviors	NULL
of	NULL
OL	NULL
2	NULL
and	NULL
OL	NULL
3	NULL
in	NULL
these	NULL
experiments	NULL
,	NULL
it	NULL
is	NULL
concluded	NULL
that	NULL
a	NULL
12-bp	NULL
DNA	NULL
region	NULL
,	NULL
where	NULL
OL	NULL
2	NULL
overlaps	NULL
with	NULL
OL	NULL
3	NULL
but	NULL
not	NULL
with	NULL
OL	NULL
1	NULL
(	NULL
residues	NULL
-504	NULL
through	NULL
-491	NULL
[	NULL
underlined	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
]	NULL
)	NULL
,	NULL
contains	NULL
the	NULL
binding	NULL
site	NULL
(	NULL
s	NULL
)	NULL
for	NULL
both	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

Identical	NULL
DNA	NULL
sequence	NULL
recognized	NULL
by	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

Segments	NULL
of	NULL
the	NULL
32-bp	NULL
sequence	NULL
of	NULL
OL	NULL
2	NULL
were	NULL
then	NULL
mutated	NULL
to	NULL
test	NULL
their	NULL
effects	NULL
on	NULL
complex	NULL
formation	NULL
(	NULL
oligonucleotides	NULL
M	NULL
1	NULL
to	NULL
4	NULL
,	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

M	NULL
3	NULL
and	NULL
M	NULL
4	NULL
,	NULL
representing	NULL
mutation	NULL
in	NULL
the	NULL
12-bp	NULL
putative	NULL
binding	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
,	NULL
and	NULL
M	NULL
1	NULL
and	NULL
M2	NULL
,	NULL
containing	NULL
irrelevant	NULL
mutation	NULL
in	NULL
the	NULL
flanking	NULL
region	NULL
,	NULL
were	NULL
synthesized	NULL
and	NULL
similarly	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
competition	NULL
assay	NULL
.	NULL

M	NULL
1	NULL
competed	NULL
for	NULL
the	NULL
binding	NULL
as	NULL
effectively	NULL
as	NULL
the	NULL
wild-type	NULL
OL	NULL
2	NULL
,	NULL
whereas	NULL
M	NULL
2	NULL
and	NULL
M	NULL
4	NULL
only	NULL
partially	NULL
competed	NULL
,	NULL
and	NULL
M	NULL
3	NULL
failed	NULL
to	NULL
compete	NULL
at	NULL
all	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
both	NULL
B1	NULL
and	NULL
B2	NULL
complexes	NULL
were	NULL
formed	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
proteins	NULL
through	NULL
a	NULL
central	NULL
sequence	NULL
,	NULL
5'-GGAAGT	NULL
,	NULL
defined	NULL
by	NULL
mutant	NULL
M	NULL
3	NULL
,	NULL
and	NULL
a	NULL
couple	NULL
of	NULL
the	NULL
adjacent	NULL
residues	NULL
defined	NULL
by	NULL
mutants	NULL
M	NULL
2	NULL
and	NULL
M	NULL
4	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
protein-binding	NULL
residues	NULL
in	NULL
more	NULL
detail	NULL
,	NULL
we	NULL
then	NULL
used	NULL
one-point	NULL
(	NULL
OP	NULL
)	NULL
mutated	NULL
oligonucleotides	NULL
spanning	NULL
both	NULL
sides	NULL
of	NULL
the	NULL
central	NULL
sequence	NULL
in	NULL
the	NULL
binding	NULL
competition	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
assay	NULL
(	NULL
OP	NULL
1	NULL
to	NULL
10	NULL
[	NULL
Fig	NULL
.	NULL

4BJ	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
5	NULL
OPs	NULL
(	NULL
OP	NULL
1	NULL
to	NULL
5	NULL
)	NULL
,	NULL
OP	NULL
1	NULL
and	NULL
OP	NULL
2	NULL
competed	NULL
for	NULL
the	NULL
binding	NULL
as	NULL
effectively	NULL
as	NULL
the	NULL
wild-type	NULL
oligonucleotide	NULL
,	NULL
whereas	NULL
OP	NULL
3	NULL
and	NULL
OP	NULL
4	NULL
only	NULL
partially	NULL
competed	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
the	NULL
5	NULL
'	NULL
edge	NULL
of	NULL
the	NULL
protein-binding	NULL
sequence	NULL
is	NULL
the	NULL
adenine	NULL
located	NULL
at	NULL
position	NULL
-505	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
OP	NULL
3	NULL
.	NULL

Surprisingly	NULL
,	NULL
OP	NULL
5	NULL
appeared	NULL
to	NULL
have	NULL
stronger	NULL
binding	NULL
affinity	NULL
for	NULL
DNA	NULL
,	NULL
since	NULL
it	NULL
competed	NULL
more	NULL
effectively	NULL
than	NULL
the	NULL
wild-type	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

In	NULL
the	NULL
direct	NULL
binding	NULL
assay	NULL
,	NULL
OP	NULL
5	NULL
indeed	NULL
displayed	NULL
enhanced	NULL
complex	NULL
formation	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
all	NULL
3	NULL
'	NULL
OPs	NULL
(	NULL
OP	NULL
8	NULL
to	NULL
10	NULL
)	NULL
showed	NULL
the	NULL
same	NULL
competition	NULL
profile	NULL
as	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
the	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
central	NULL
sequence	NULL
were	NULL
further	NULL
mutated	NULL
(	NULL
OP	NULL
6	NULL
and	NULL
OP	NULL
7	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
two	NULL
oligonucleotides	NULL
prepared	NULL
,	NULL
OP	NULL
6	NULL
could	NULL
not	NULL
compete	NULL
for	NULL
the	NULL
binding	NULL
,	NULL
whereas	NULL
OP	NULL
7	NULL
did	NULL
to	NULL
some	NULL
extent	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
thymine	NULL
located	NULL
at	NULL
position	NULL
-497	NULL
,	NULL
mutated	NULL
in	NULL
OP	NULL
7	NULL
,	NULL
is	NULL
the	NULL
3	NULL
'	NULL
terminus	NULL
of	NULL
the	NULL
binding	NULL
sequence	NULL
and	NULL
that	NULL
the	NULL
guanine	NULL
,	NULL
located	NULL
at	NULL
position	NULL
-498	NULL
,	NULL
substituted	NULL
in	NULL
OP	NULL
6	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
protein	NULL
binding	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
B1	NULL
and	NULL
B2	NULL
exhibited	NULL
identical	NULL
competition	NULL
profiles	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
mutated	NULL
oligonucleotides	NULL
M	NULL
2	NULL
to	NULL
4	NULL
and	NULL
OP	NULL
3	NULL
to	NULL
7	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
results	NULL
,	NULL
the	NULL
sequence	NULL
requirement	NULL
and	NULL
the	NULL
binding	NULL
specificity	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
are	NULL
most	NULL
likely	NULL
identical	NULL
(	NULL
residues	NULL
-505	NULL
through	NULL
-497	NULL
,	NULL
mutated	NULL
in	NULL
OP	NULL
3	NULL
to	NULL
5	NULL
and	NULL
M	NULL
3	NULL
)	NULL
.	NULL

We	NULL
shall	NULL
refer	NULL
to	NULL
this	NULL
purine-rich	NULL
9-mer	NULL
sequence	NULL
,	NULL
5	NULL
!	NULL

-ACAGGAAGT	NULL
(	NULL
-505	NULL
to	NULL
-497	NULL
)	NULL
,	NULL
hereafter	NULL
as	NULL
the	NULL
NF-P	NULL
motif	NULL
.	NULL

Subsequent	NULL
sequence	NULL
comparison	NULL
revealed	NULL
the	NULL
location	NULL
of	NULL
the	NULL
human	NULL
cognate	NULL
NF-P	NULL
motif	NULL
,	NULL
5'-gCAGGAAGT	NULL
,	NULL
being	NULL
between	NULL
residues	NULL
-618	NULL
and	NULL
-610	NULL
of	NULL
human	NULL
Pfp	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Positive	NULL
regulatory	NULL
function	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
9-mer	NULL
sequence	NULL
identified	NULL
above	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
positive	NULL
regulatory	NULL
function	NULL
originally	NULL
observed	NULL
for	NULL
the	NULL
pCAT_	NULL
,	NULL
,	NULL
,	NULL
reporter	NULL
construct	NULL
,	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
in	NULL
tandem	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
residues	NULL
-522	NULL
through	NULL
-491	NULL
sequence	NULL
was	NULL
linked	NULL
5	NULL
'	NULL
to	NULL
the	NULL
Pfp	NULL
sequence	NULL
in	NULL
the	NULL
pCAT_,4	NULL
,	NULL
,	NULL
construct	NULL
.	NULL

This	NULL
construct	NULL
(	NULL
designated	NULL
pCATai	NULL
,	NULL
.	NULL

,	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
CTLL-R8	NULL
and	NULL
non-CTL	NULL
EL-4	NULL
cefls	NULL
,	NULL
and	NULL
the	NULL
CAT	NULL
enzyme	NULL
activity	NULL
was	NULL
monitored	NULL
in	NULL
the	NULL
transfected	NULL
cell	NULL
lysates	NULL
.	NULL

In	NULL
several	NULL
repeating	NULL
experiments	NULL
,	NULL
increased	NULL
CAT	NULL
expression	NULL
over	NULL
that	NULL
driven	NULL
by	NULL
pCAT	NULL
_	NULL
,	NULL
,	NULL
,	NULL
was	NULL
found	NULL
in	NULL
CTLL-R8	NULL
but	NULL
not	NULL
in	NULL
EL-4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
an	NULL
intermediate	NULL
level	NULL
of	NULL
enhancement	NULL
of	NULL
CAT	NULL
expression	NULL
occurred	NULL
when	NULL
the	NULL
pCAT	NULL
,	NULL
;	NULL
;	NULL
,	NULL
,	NULL
was	NULL
transfected	NULL
into	NULL
CTLL-R8	NULL
cultured	NULL
in	NULL
medium	NULL
without	NULL
IL-2	NULL
[	NULL
CTLL-R8	NULL
(	NULL
NC	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
]	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
observed	NULL
positive	NULL
regulatory	NULL
activity	NULL
is	NULL
killer	NULL
cell	NULL
specific	NULL
,	NULL
IL-2	NULL
inducible	NULL
,	NULL
and	NULL
likely	NULL
mediated	NULL
by	NULL
the	NULL
NF-P	NULL
motif	NULL
,	NULL
as	NULL
no	NULL
other	NULL
protein-binding	NULL
sequence	NULL
has	NULL
been	NULL
identified	NULL
within	NULL
this	NULL
region	NULL
.	NULL

Since	NULL
pCAT_	NULL
;	NULL
,	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
more	NULL
efficient	NULL
than	NULL
pCAT	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
in	NULL
enhancing	NULL
the	NULL
CAT	NULL
expression	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
additional	NULL
positive	NULL
regulatory	NULL
elements	NULL
are	NULL
present	NULL
within	NULL
the	NULL
region	NULL
of	NULL
residues	NULL
-412	NULL
through	NULL
-566	NULL
still	NULL
can	NULL
not	NULL
be	NULL
ruled	NULL
out	NULL
.	NULL

To	NULL
verify	NULL
further	NULL
the	NULL
role	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
Pfp	NULL
,	NULL
two	NULL
reporter	NULL
constructs	NULL
containing	NULL
the	NULL
Pfp	NULL
sequence	NULL
spanning	NULL
from	NULL
residue	NULL
+62	NULL
to	NULL
residue	NULL
-522	NULL
with	NULL
the	NULL
NF-P	NULL
motif	NULL
being	NULL
mutated	NULL
[	NULL
5-CACGGAAGT-3	NULL
'	NULL
(	NULL
pCATy	NULL
;	NULL
;	NULL
)	NULL
and	NULL
5'-ACATTCCTG-3	NULL
'	NULL
(	NULL
pCATy	NULL
;	NULL
,	NULL
)	NULL
;	NULL
mutated	NULL
as	NULL
underlined	NULL
]	NULL
were	NULL
prepared	NULL
.	NULL

Analyses	NULL
with	NULL
the	NULL
lysates	NULL
of	NULL
CTLL-R8	NULL
transfected	NULL
with	NULL
these	NULL
constructs	NULL
showed	NULL
little	NULL
or	NULL
virtually	NULL
no	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
not	NULL
only	NULL
is	NULL
important	NULL
for	NULL
enhancing	NULL
Pfp	NULL
expression	NULL
but	NULL
also	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
normal	NULL
function	NULL
of	NULL
downstream	NULL
regulatory	NULL
sequences	NULL
.	NULL

It	NULL
appears	NULL
also	NULL
that	NULL
the	NULL
5	NULL
'	NULL
sequence	NULL
flanking	NULL
the	NULL
KILLER	NULL
CELL-SPECIFIC	NULL
REGULATORY	NULL
ELEMENT	NULL
OF	NULL
MOUSE	NULL
Pfp	NULL
6695	NULL
A	NULL
EL-4	NULL
CTLL-R8	NULL
@	NULL
R	NULL
&	NULL
PCAT	NULL
)	NULL
~	NULL
@	NULL
@	NULL
@	NULL
<	NULL
Â»	NULL
C	NULL
@	NULL
@	NULL
-	NULL
<	NULL
#	NULL
.	NULL

PCATpigo	NULL
-	NULL
@	NULL
%	NULL
+	NULL
&	NULL
B	NULL
10906	NULL
e	NULL
za	NULL
=	NULL
in	NULL
activity	NULL
Relative	NULL
CAT	NULL
G	NULL
400	NULL
g	NULL
3004	NULL
T	NULL
'	NULL
>	NULL
|	NULL
bai	NULL
|	NULL
<	NULL
<	NULL
200	NULL
O	NULL
Â®	NULL
2s	NULL
s	NULL
[	NULL
8	NULL
4	NULL
CC	NULL
100	NULL
Jp	NULL
0	NULL
â	NULL
_	NULL
___|	NULL
pCATgy4o	NULL
pCATa4q	NULL
pCAT.see	NULL
pCATupq	NULL
pCATgq	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
.	NULL

(	NULL
A	NULL
)	NULL
CTLL-R8	NULL
and	NULL
EL-4	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
of	NULL
the	NULL
three	NULL
reporter	NULL
con-structs	NULL
:	NULL
pCAT_411	NULL
,	NULL
PCATongo	NULL
,	NULL
and	NULL
(	NULL
see	NULL
text	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
in	NULL
cell	NULL
lysate	NULL
was	NULL
analyzed	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
were	NULL
derived	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
appropriate	NULL
construct	NULL
was	NULL
measured	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

The	NULL
activities	NULL
were	NULL
normalized	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
transfection	NULL
efficiency	NULL
and	NULL
compared	NULL
with	NULL
the	NULL
background	NULL
expression	NULL
driven	NULL
by	NULL
the	NULL
control	NULL
plasmid	NULL
vector	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
represent	NULL
the	NULL
mean	NULL
values	NULL
derived	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

pCATy	NULL
;	NULL
,	NULL
and	NULL
pCATpy	NULL
;	NULL
,	NULL
contain	NULL
mutations	NULL
at	NULL
residues	NULL
-505	NULL
to	NULL
-503	NULL
and	NULL
-502	NULL
to	NULL
-497	NULL
,	NULL
respectively	NULL
(	NULL
see	NULL
text	NULL
)	NULL
.	NULL

GGAA/T	NULL
core	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
.	NULL

Relationship	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
with	NULL
Ets	NULL
proteins	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
sequence	NULL
comparison	NULL
,	NULL
the	NULL
purine-rich	NULL
NF-P	NULL
motif	NULL
appeared	NULL
to	NULL
be	NULL
reminiscent	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
protein	NULL
products	NULL
of	NULL
the	NULL
ets	NULL
proto-oncogene	NULL
family	NULL
(	NULL
consensus	NULL
core	NULL
6696	NULL
KOIZUMI	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

A	NULL
B	NULL
c	NULL
&	NULL
Probe	NULL
oL	NULL
2	NULL
Ets-1	NULL
Probe	NULL
or	NULL
?	NULL

NF-AT/EIf1	NULL
&	NULL
&	NULL
I	NULL
Nf	NULL
1	NULL
I	NULL
1T	NULL
1	NULL
&	NULL
g	NULL
OL2	NULL
_	NULL
Ets-1	NULL
OL	NULL
2	NULL
___	NULL
Ets-1	NULL
OL	NULL
2	NULL
Elf-1	NULL
or2	NULL
.	NULL

_	NULL
fifi	NULL
hG	NULL
a	NULL
T	NULL
C	NULL
Comp	NULL
.	NULL

of	NULL
7	NULL
r	NULL
Tor	NULL
1	NULL
.	NULL

omp	NULL
.	NULL

S	NULL
3	NULL
8	NULL
s	NULL
S	NULL
s-	NULL
8	NULL
s.	NULL
5	NULL
s	NULL
:	NULL
.	NULL

:6	NULL
(	NULL
s|	NULL
18	NULL
a	NULL
a	NULL
i	NULL
O	NULL
i	NULL
Â®	NULL
in	NULL
O	NULL
[	NULL
tl	NULL
O	NULL
w	NULL
O	NULL
has	NULL
X	NULL
X	NULL
X	NULL
X	NULL
X	NULL
X	NULL
-	NULL
%	NULL
I	NULL
X	NULL
X	NULL
X	NULL
X	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Relationship	NULL
between	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
NF-AT/EIf-1	NULL
,	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Competition	NULL
assays	NULL
with	NULL
OL	NULL
2	NULL
and	NULL
Ets-1	NULL
oligonucleotides	NULL
.	NULL

NE	NULL
of	NULL
CTLL-R8	NULL
cells	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
Comp	NULL
.	NULL
)	NULL

(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
50-fold	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
,	NULL
OL	NULL
2	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
,	NULL
Ets-1	NULL
)	NULL
or	NULL
200-fold	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
,	NULL
OL	NULL
2	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
,	NULL
Ets-1	NULL
)	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitors	NULL
,	NULL
and	NULL
then	NULL
end-labeled	NULL
OL	NULL
2	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
or	NULL
the	NULL
Ets-1	NULL
probe	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Both	NULL
oligonucleotides	NULL
consist	NULL
of	NULL
32	NULL
bp	NULL
.	NULL

The	NULL
specific	NULL
Ets-1	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Competition	NULL
assays	NULL
with	NULL
OL	NULL
2	NULL
and	NULL
NF-AT/Elf-1	NULL
oligonucleotides	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
performed	NULL
as	NULL
for	NULL
panel	NULL
A	NULL
,	NULL
except	NULL
that	NULL
a	NULL
30-bp	NULL
NF-AT/EIf-1	NULL
oligonucleotide	NULL
was	NULL
used	NULL
instead	NULL
of	NULL
the	NULL
Ets-1	NULL
oligonucleotide	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
at	NULL
20Â°C	NULL
.	NULL

The	NULL
arrow	NULL
points	NULL
to	NULL
the	NULL
specific	NULL
NF-AT/EIf-1	NULL
complex	NULL
.	NULL

(	NULL
C	NULL
)	NULL
NE	NULL
of	NULL
CTLL-R8	NULL
cells	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
appropriate	NULL
antibody	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
end-labeled	NULL
OL	NULL
2	NULL
probe	NULL
.	NULL

sequence	NULL
,	NULL
A/CGGAA	NULL
,	NULL
/T	NULL
)	NULL
(	NULL
7	NULL
,	NULL
16	NULL
,	NULL
20	NULL
,	NULL
31	NULL
,	NULL
45	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
are	NULL
Ets-related	NULL
proteins	NULL
,	NULL
two	NULL
members	NULL
of	NULL
Ets	NULL
protein	NULL
family	NULL
,	NULL
Ets-l	NULL
and	NULL
NF-AT/Ef-1	NULL
,	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
or	NULL
thymocytes	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
13	NULL
,	NULL
14	NULL
,	NULL
36	NULL
,	NULL
38	NULL
)	NULL
,	NULL
were	NULL
compared	NULL
with	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
in	NULL
EMSA	NULL
.	NULL

A	NULL
32-bp	NULL
oligonucleotide	NULL
comprising	NULL
the	NULL
native	NULL
Ets-1	NULL
binding	NULL
site	NULL
of	NULL
human	NULL
T-cell	NULL
receptor	NULL
Â«	NULL
-chain	NULL
gene	NULL
enhancer	NULL
(	NULL
core	NULL
sequence	NULL
,	NULL
AGGAT	NULL
)	NULL
(	NULL
13	NULL
)	NULL
and	NULL
a	NULL
30-bp	NULL
oligonucleotide	NULL
consisting	NULL
of	NULL
the	NULL
native	NULL
NF-AT	NULL
binding	NULL
site	NULL
(	NULL
recently	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
Elf-1	NULL
and	NULL
another	NULL
factor	NULL
[	NULL
14	NULL
,	NULL
38	NULL
]	NULL
)	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
enhancer	NULL
(	NULL
core	NULL
sequence	NULL
,	NULL
AGGAA	NULL
,	NULL
same	NULL
as	NULL
the	NULL
NF-P	NULL
motif	NULL
)	NULL
(	NULL
12	NULL
)	NULL
were	NULL
used	NULL
in	NULL
EMSA	NULL
,	NULL
in	NULL
comparison	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
to	NULL
OL	NULL
2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
the	NULL
putative	NULL
Ets-l	NULL
or	NULL
NF-AT/EIf-1	NULL
complex	NULL
migrated	NULL
much	NULL
more	NULL
slowly	NULL
than	NULL
B1	NULL
or	NULL
B2	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
molecular	NULL
masses	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
differ	NULL
significantly	NULL
from	NULL
those	NULL
of	NULL
the	NULL
two	NULL
Ets	NULL
proteins	NULL
.	NULL

To	NULL
further	NULL
distinguish	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
from	NULL
Ets-1l	NULL
and	NULL
Ets-2	NULL
,	NULL
EMSA	NULL
with	NULL
OL	NULL
2	NULL
as	NULL
the	NULL
probe	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
either	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
)	NULL
.	NULL

These	NULL
antibodies	NULL
neither	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
B1	NULL
and	NULL
B2	NULL
nor	NULL
shifted	NULL
the	NULL
positions	NULL
of	NULL
these	NULL
complexes	NULL
to	NULL
a	NULL
higher-molecular-weight	NULL
region	NULL
(	NULL
the	NULL
so-called	NULL
supershift	NULL
[	NULL
5	NULL
]	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
specific	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
epitopes	NULL
recognized	NULL
by	NULL
the	NULL
monoclonal	NULL
antibodies	NULL
tested	NULL
are	NULL
not	NULL
present	NULL
in	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

In	NULL
the	NULL
binding	NULL
competition	NULL
analysis	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
to	NULL
labeled	NULL
OL	NULL
2	NULL
was	NULL
efficiently	NULL
inhibited	NULL
by	NULL
unlabeled	NULL
OL	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
only	NULL
slightly	NULL
inhibited	NULL
by	NULL
the	NULL
Ets-1	NULL
oligonucleotide	NULL
and	NULL
not	NULL
at	NULL
all	NULL
inhibited	NULL
by	NULL
the	NULL
NF-AT/EIf-1	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
unlabeled	NULL
OL	NULL
2	NULL
failed	NULL
to	NULL
inhibit	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
when	NULL
labeled	NULL
Ets-1	NULL
or	NULL
NF-AT/EIf-1	NULL
probe	NULL
was	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
are	NULL
distinct	NULL
from	NULL
Ets-1	NULL
and	NULL
NF-AT/EIf-1	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
weak	NULL
cross-competition	NULL
observed	NULL
between	NULL
OL	NULL
2	NULL
and	NULL
Ets-1	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
implies	NULL
that	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
still	NULL
overlap	NULL
with	NULL
Ets-1	NULL
to	NULL
a	NULL
certain	NULL
degree	NULL
in	NULL
terms	NULL
of	NULL
their	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
are	NULL
also	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
.	NULL

They	NULL
are	NULL
,	NULL
however	NULL
,	NULL
only	NULL
distantly	NULL
related	NULL
to	NULL
Ets-1	NULL
.	NULL

Similar-size	NULL
DNA-binding	NULL
subunits	NULL
present	NULL
in	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

To	NULL
estimate	NULL
the	NULL
native	NULL
molecular	NULL
masses	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
,	NULL
NE	NULL
prepared	NULL
from	NULL
resting	NULL
CTLL-R8	NULL
cells	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
size-exclusion	NULL
column	NULL
,	NULL
and	NULL
a	NULL
portion	NULL
of	NULL
each	NULL
fraction	NULL
collected	NULL
was	NULL
assayed	NULL
by	NULL
EMSA	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
B1	NULL
and	NULL
B2	NULL
complexes	NULL
.	NULL

Maximal	NULL
B1	NULL
and	NULL
B2	NULL
formations	NULL
were	NULL
detected	NULL
in	NULL
fractions	NULL
45	NULL
and	NULL
55	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
with	NULL
molecular	NULL
mass	NULL
standards	NULL
,	NULL
the	NULL
native	NULL
molecular	NULL
masses	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
were	NULL
estimated	NULL
to	NULL
be	NULL
in	NULL
the	NULL
range	NULL
of	NULL
208	NULL
to	NULL
234	NULL
and	NULL
91	NULL
to	NULL
100	NULL
kDa	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
partially	NULL
purified	NULL
NF-P1	NULL
or	NULL
NF-P2	NULL
was	NULL
also	NULL
examined	NULL
by	NULL
EMSA	NULL
with	NULL
two	NULL
mutant	NULL
DNA	NULL
probes	NULL
,	NULL
M	NULL
3	NULL
and	NULL
OP	NULL
6	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
showed	NULL
that	NULL
neither	NULL
of	NULL
the	NULL
two	NULL
mutant	NULL
probes	NULL
formed	NULL
B1	NULL
or	NULL
B2	NULL
complexes	NULL
with	NULL
the	NULL
two	NULL
factors	NULL
present	NULL
in	NULL
the	NULL
column	NULL
fractions	NULL
(	NULL
not	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
B	NULL
Mr	NULL
(	NULL
kD	NULL
)	NULL
Mr	NULL
(	NULL
kD	NULL
)	NULL
B1	NULL
B2	NULL
200	NULL
-	NULL
Â«	NULL
s	NULL
97	NULL
-	NULL
Cys	NULL
:	NULL
69	NULL
-	NULL
$	NULL
|	NULL
200	NULL
46	NULL
30	NULL
&	NULL
2	NULL
97	NULL
69	NULL
46	NULL
KILLER	NULL
CELL-SPECIFIC	NULL
REGULATORY	NULL
ELEMENT	NULL
OF	NULL
MOUSE	NULL
Pfp	NULL
gvesgmad	NULL
6697	NULL
2	NULL
32	NULL
.	NULL

4Â°	NULL
6	NULL
-	NULL
Mr	NULL
(	NULL
kD	NULL
)	NULL
-	NULL
200	NULL
-	NULL
.	NULL

:	NULL
97	NULL
-	NULL
69	NULL
2416	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Molecular	NULL
masses	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Size-exclusion	NULL
chromatography	NULL
.	NULL

Two	NULL
milligrams	NULL
of	NULL
NE	NULL
of	NULL
CTLL-R8	NULL
cells	NULL
was	NULL
loaded	NULL
on	NULL
a	NULL
Sephacryl	NULL
$	NULL
-300	NULL
column	NULL
(	NULL
50-ml	NULL
column	NULL
volume	NULL
;	NULL
Pharmacia	NULL
)	NULL
that	NULL
had	NULL
been	NULL
equilibrated	NULL
in	NULL
0.1	NULL
M	NULL
KCl-buffer	NULL
D	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
0.5-ml	NULL
fractions	NULL
were	NULL
collected	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
0.5	NULL
ml/min	NULL
.	NULL

Aliquots	NULL
(	NULL
20	NULL
wl	NULL
)	NULL
of	NULL
each	NULL
fraction	NULL
were	NULL
incubated	NULL
with	NULL
labeled	NULL
OL	NULL
2	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
EMSA	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
molecular	NULL
weight	NULL
standards	NULL
eluted	NULL
are	NULL
indicated	NULL
on	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

(	NULL
B	NULL
)	NULL
UV	NULL
cross-linking	NULL
analysis	NULL
of	NULL
the	NULL
B1	NULL
and	NULL
B2	NULL
complexes	NULL
.	NULL

B1	NULL
and	NULL
B2	NULL
were	NULL
resolved	NULL
by	NULL
EMSA	NULL
and	NULL
subjected	NULL
to	NULL
UV	NULL
irradiation	NULL
in	NULL
situ	NULL
.	NULL

The	NULL
cross-linked	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
electroeluted	NULL
and	NULL
analyzed	NULL
on	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
reducing	NULL
conditions	NULL
.	NULL

Left	NULL
and	NULL
right	NULL
lanes	NULL
,	NULL
cross-linked	NULL
B1	NULL
and	NULL
B2	NULL
complexes	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
C	NULL
)	NULL
UV	NULL
cross-linking	NULL
analysis	NULL
of	NULL
the	NULL
B1	NULL
and	NULL
B2	NULL
complexes	NULL
.	NULL

In	NULL
situ	NULL
UV	NULL
cross-linking	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Stratalinker	NULL
.	NULL

The	NULL
B1	NULL
and	NULL
B2	NULL
complexes	NULL
were	NULL
eluted	NULL
by	NULL
passive	NULL
diffusion	NULL
at	NULL
4Â°C	NULL
and	NULL
analyzed	NULL
on	NULL
an	NULL
SDS-6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
UV-cross-linked	NULL
B1	NULL
and	NULL
B2	NULL
,	NULL
respectively	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
area	NULL
corresponding	NULL
to	NULL
B1	NULL
on	NULL
EMSA	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extract	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
,	NULL
un-cross-linked	NULL
B1	NULL
and	NULL
B2	NULL
,	NULL
respectively	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
UV-cross-linked	NULL
irrelevant	NULL
DNA-protein	NULL
complex	NULL
.	NULL

shown	NULL
)	NULL
.	NULL

In	NULL
situ	NULL
UV	NULL
cross-linking	NULL
was	NULL
then	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
molecular	NULL
components	NULL
and	NULL
the	NULL
masses	NULL
of	NULL
both	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
under	NULL
denaturing	NULL
conditions	NULL
.	NULL

In	NULL
some	NULL
earlier	NULL
experiments	NULL
in	NULL
which	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
electroeluted	NULL
overnight	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
cross-linked	NULL
B1	NULL
and	NULL
B2	NULL
were	NULL
found	NULL
to	NULL
contain	NULL
several	NULL
similar-size	NULL
polypeptide	NULL
species	NULL
:	NULL
two	NULL
major	NULL
ones	NULL
of	NULL
~90	NULL
and	NULL
~40	NULL
kDa	NULL
and	NULL
,	NULL
occasionally	NULL
,	NULL
a	NULL
minor	NULL
one	NULL
of	NULL
~30	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Since	NULL
proteolysis	NULL
or	NULL
photocleavage	NULL
(	NULL
10	NULL
)	NULL
of	NULL
proteins	NULL
under	NULL
harsh	NULL
experimental	NULL
conditions	NULL
was	NULL
a	NULL
serious	NULL
concern	NULL
,	NULL
we	NULL
later	NULL
adopted	NULL
a	NULL
milder	NULL
UV	NULL
cross-linking	NULL
and	NULL
protein	NULL
elution	NULL
pro-tocol	NULL
.	NULL

After	NULL
UV	NULL
irradiation	NULL
,	NULL
the	NULL
gel	NULL
slices	NULL
were	NULL
incubated	NULL
at	NULL
4Â°C	NULL
overnight	NULL
in	NULL
soaking	NULL
buffer	NULL
containing	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
during	NULL
which	NULL
time	NULL
DNA-protein	NULL
complexes	NULL
would	NULL
passively	NULL
diffuse	NULL
into	NULL
the	NULL
buffer	NULL
.	NULL

Upon	NULL
electrophoresis	NULL
on	NULL
SDS-6	NULL
%	NULL
PAGE	NULL
(	NULL
for	NULL
better	NULL
resolution	NULL
of	NULL
the	NULL
high-molecular-weight	NULL
species	NULL
)	NULL
under	NULL
reducing	NULL
conditions	NULL
,	NULL
the	NULL
~90-kDa	NULL
species	NULL
was	NULL
resolved	NULL
into	NULL
two	NULL
polypeptide	NULL
species	NULL
migrating	NULL
closely	NULL
at	NULL
around	NULL
80	NULL
to	NULL
90	NULL
kDa	NULL
;	NULL
this	NULL
was	NULL
found	NULL
for	NULL
both	NULL
the	NULL
B1	NULL
and	NULL
B2	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

These	NULL
two	NULL
80-	NULL
to	NULL
90-kDa	NULL
species	NULL
may	NULL
represent	NULL
either	NULL
two	NULL
different	NULL
subunits	NULL
with	NULL
similar	NULL
molecular	NULL
masses	NULL
or	NULL
,	NULL
instead	NULL
,	NULL
isoforms	NULL
of	NULL
the	NULL
same	NULL
protein	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
dominant	NULL
doublet	NULL
bands	NULL
,	NULL
two	NULL
more	NULL
slowly	NULL
migrating	NULL
bands	NULL
were	NULL
found	NULL
in	NULL
the	NULL
B1	NULL
complex	NULL
but	NULL
not	NULL
in	NULL
the	NULL
B2	NULL
complex	NULL
eluate	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Lower-molecular-weight	NULL
species	NULL
,	NULL
probably	NULL
generated	NULL
because	NULL
of	NULL
incomplete	NULL
inhibition	NULL
of	NULL
proteolysis	NULL
,	NULL
were	NULL
still	NULL
detected	NULL
.	NULL

The	NULL
cross-linked	NULL
DNA-protein	NULL
complexes	NULL
eluted	NULL
from	NULL
an	NULL
irrelevant	NULL
third	NULL
band	NULL
did	NULL
not	NULL
contain	NULL
the	NULL
two	NULL
species	NULL
migrating	NULL
at	NULL
around	NULL
80	NULL
to	NULL
90	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
80-	NULL
to	NULL
90-kDa	NULL
doublet	NULL
species	NULL
were	NULL
unique	NULL
for	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

These	NULL
80-	NULL
to	NULL
90-kDa	NULL
protein	NULL
species	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
when	NULL
the	NULL
nuclear	NULL
extract	NULL
was	NULL
not	NULL
added	NULL
during	NULL
EMSA	NULL
or	NULL
if	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
not	NULL
subjected	NULL
to	NULL
UV	NULL
irradiation	NULL
prior	NULL
to	NULL
SDS-PAGE	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
5	NULL
)	NULL
,	NULL
which	NULL
indicated	NULL
that	NULL
the	NULL
association	NULL
between	NULL
the	NULL
proteins	NULL
and	NULL
oligonucleotides	NULL
was	NULL
specific	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
share	NULL
a	NULL
common	NULL
DNA-binding	NULL
subunit	NULL
(	NULL
s	NULL
)	NULL
.	NULL

That	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
differ	NULL
in	NULL
native	NULL
molecular	NULL
mass	NULL
but	NULL
share	NULL
similar-size	NULL
DNA-binding	NULL
subunits	NULL
suggests	NULL
that	NULL
NF-P1	NULL
differs	NULL
from	NULL
NF-P2	NULL
by	NULL
having	NULL
additional	NULL
non-DNA-binding	NULL
subunits	NULL
.	NULL

It	NULL
is	NULL
speculated	NULL
that	NULL
the	NULL
higher-molecular-weight	NULL
species	NULL
present	NULL
in	NULL
the	NULL
B1	NULL
complex	NULL
eluate	NULL
might	NULL
represent	NULL
cross-linked	NULL
entities	NULL
which	NULL
contain	NULL
both	NULL
the	NULL
DNA-binding	NULL
and	NULL
the	NULL
non-DNA-binding	NULL
subunit	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Additional	NULL
experiments	NULL
,	NULL
in	NULL
particular	NULL
the	NULL
V8	NULL
6698	NULL
KOJIZUMI	NULL
ET	NULL
AL	NULL
.	NULL

mapping	NULL
,	NULL
are	NULL
being	NULL
carried	NULL
out	NULL
to	NULL
clarify	NULL
whether	NULL
the	NULL
similar-size	NULL
DNA-binding	NULL
subunits	NULL
present	NULL
in	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
are	NULL
in	NULL
fact	NULL
identical	NULL
.	NULL

DISCUSSION	NULL
During	NULL
CTL	NULL
activation	NULL
,	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
,	NULL
including	NULL
that	NULL
encoding	NULL
perforin	NULL
,	NULL
become	NULL
transcriptionally	NULL
active	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
tight	NULL
regulation	NULL
of	NULL
the	NULL
perforin	NULL
gene	NULL
,	NULL
we	NULL
have	NULL
attempted	NULL
to	NULL
dissect	NULL
the	NULL
mechanisms	NULL
controlling	NULL
its	NULL
expression	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
partially	NULL
elucidated	NULL
the	NULL
promoter	NULL
and	NULL
regulatory	NULL
sequences	NULL
for	NULL
mouse	NULL
Pfp	NULL
by	NULL
using	NULL
CAT	NULL
reporter	NULL
constructs	NULL
.	NULL

We	NULL
have	NULL
concentrated	NULL
on	NULL
studying	NULL
the	NULL
5'-flanking	NULL
sequences	NULL
only	NULL
up	NULL
to	NULL
residue	NULL
-700	NULL
,	NULL
since	NULL
the	NULL
promoter	NULL
and	NULL
important	NULL
regulatory	NULL
elements	NULL
for	NULL
most	NULL
genes	NULL
usually	NULL
reside	NULL
not	NULL
too	NULL
far	NULL
away	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

Results	NULL
obtained	NULL
in	NULL
our	NULL
present	NULL
study	NULL
showed	NULL
that	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
up	NULL
to	NULL
residue	NULL
-141	NULL
contains	NULL
an	NULL
essential	NULL
promoter	NULL
activity	NULL
for	NULL
Pfp	NULL
,	NULL
which	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
report	NULL
published	NULL
while	NULL
this	NULL
paper	NULL
was	NULL
being	NULL
prepared	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Sequence	NULL
comparison	NULL
has	NULL
revealed	NULL
several	NULL
potential	NULL
regulatory	NULL
elements	NULL
,	NULL
including	NULL
the	NULL
TATA	NULL
box-like	NULL
,	NULL
GC	NULL
box-like	NULL
,	NULL
and	NULL
AP-2	NULL
binding	NULL
site-like	NULL
elements	NULL
present	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
.	NULL

In	NULL
our	NULL
present	NULL
study	NULL
,	NULL
a	NULL
positive	NULL
and	NULL
a	NULL
negative	NULL
regulatory	NULL
function	NULL
were	NULL
identified	NULL
in	NULL
the	NULL
regions	NULL
of	NULL
residues	NULL
-412	NULL
through	NULL
-566	NULL
and	NULL
-567	NULL
through	NULL
-700	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
judged	NULL
from	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
Pfp	NULL
promoter	NULL
and	NULL
the	NULL
upstream	NULL
regions	NULL
appeared	NULL
to	NULL
regulate	NULL
gene	NULL
expression	NULL
efficiently	NULL
in	NULL
CTLs	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
constructs	NULL
,	NULL
they	NULL
also	NULL
drove	NULL
the	NULL
gene	NULL
expression	NULL
in	NULL
non-CTLs	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
.	NULL

Differing	NULL
from	NULL
the	NULL
results	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
22	NULL
)	NULL
,	NULL
we	NULL
have	NULL
not	NULL
identified	NULL
any	NULL
region	NULL
that	NULL
controls	NULL
Pfp	NULL
expression	NULL
in	NULL
a	NULL
reciprocal	NULL
fashion	NULL
in	NULL
perforin-positive	NULL
and	NULL
perforin-negative	NULL
cells	NULL
.	NULL

The	NULL
reasons	NULL
for	NULL
this	NULL
discrepancy	NULL
are	NULL
currently	NULL
unclear	NULL
.	NULL

A	NULL
more	NULL
detailed	NULL
and	NULL
extensive	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
sequences	NULL
of	NULL
mouse	NULL
Pfp	NULL
will	NULL
be	NULL
required	NULL
in	NULL
order	NULL
to	NULL
resolve	NULL
this	NULL
issue	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
focused	NULL
on	NULL
(	NULL
i	NULL
)	NULL
fine	NULL
mapping	NULL
the	NULL
positive	NULL
regulatory	NULL
element	NULL
present	NULL
between	NULL
residues	NULL
-412	NULL
and	NULL
-566	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
identifying	NULL
the	NULL
cognate	NULL
trans-acting	NULL
factors	NULL
.	NULL

By	NULL
means	NULL
of	NULL
EMSA	NULL
and	NULL
mutational	NULL
analysis	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
two	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
,	NULL
that	NULL
interact	NULL
with	NULL
a	NULL
particular	NULL
motif	NULL
within	NULL
this	NULL
region	NULL
.	NULL

These	NULL
two	NULL
proteins	NULL
displayed	NULL
three	NULL
prominent	NULL
features	NULL
.	NULL

Firstly	NULL
,	NULL
NF-P1	NULL
was	NULL
ubiquitously	NULL
found	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
examined	NULL
,	NULL
whereas	NULL
NF-P2	NULL
appeared	NULL
to	NULL
be	NULL
present	NULL
exclusively	NULL
in	NULL
killer	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Secondly	NULL
,	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
were	NULL
reciprocally	NULL
and	NULL
specifically	NULL
modulated	NULL
in	NULL
killer	NULL
cells	NULL
upon	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Thirdly	NULL
,	NULL
both	NULL
proteins	NULL
bound	NULL
to	NULL
an	NULL
identical	NULL
9-mer	NULL
purine-rich	NULL
sequence	NULL
,	NULL
5	NULL
!	NULL

-ACAGGA	NULL
AGT	NULL
(	NULL
residues	NULL
-505	NULL
through	NULL
-497	NULL
;	NULL
designated	NULL
the	NULL
NF-P	NULL
motif	NULL
[	NULL
Fig	NULL
.	NULL

4	NULL
]	NULL
)	NULL
.	NULL

All	NULL
these	NULL
three	NULL
features	NULL
suggest	NULL
the	NULL
involvement	NULL
of	NULL
NF-P1l1	NULL
and	NULL
NF-P2	NULL
in	NULL
the	NULL
cell-type-specific	NULL
Pfp	NULL
transcription	NULL
.	NULL

Sequence	NULL
comparison	NULL
revealed	NULL
that	NULL
the	NULL
NF-P	NULL
motif	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
known	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
Ets	NULL
proteins	NULL
,	NULL
which	NULL
generally	NULL
consist	NULL
of	NULL
purine-rich	NULL
9-	NULL
to	NULL
11-mer	NULL
sequences	NULL
with	NULL
a	NULL
core	NULL
motif	NULL
,	NULL
GGAA/T	NULL
(	NULL
7	NULL
,	NULL
16	NULL
,	NULL
20	NULL
,	NULL
31	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
Ets	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
products	NULL
of	NULL
the	NULL
ets	NULL
proto-oncogene	NULL
family	NULL
(	NULL
25	NULL
,	NULL
44	NULL
)	NULL
,	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
new	NULL
and	NULL
large	NULL
group	NULL
of	NULL
transcription	NULL
activators	NULL
(	NULL
16	NULL
,	NULL
25	NULL
)	NULL
involved	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
encoding	NULL
a	NULL
variety	NULL
of	NULL
proteins	NULL
across	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
cell	NULL
types	NULL
.	NULL

Several	NULL
Ets	NULL
family	NULL
members	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
T-cell-specific	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
T-cell	NULL
recep-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

tor	NULL
and	NULL
IL-2	NULL
(	NULL
13	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Since	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
are	NULL
present	NULL
in	NULL
T-cell	NULL
populations	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
we	NULL
have	NULL
specifically	NULL
examined	NULL
their	NULL
relationship	NULL
with	NULL
two	NULL
known	NULL
T-cell	NULL
Ets	NULL
proteins	NULL
,	NULL
Ets-1	NULL
and	NULL
NF-AT/Elf-1	NULL
(	NULL
13	NULL
,	NULL
36	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
from	NULL
cross-competition	NULL
experiments	NULL
showed	NULL
that	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
share	NULL
a	NULL
certain	NULL
degree	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
with	NULL
Ets-1	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
may	NULL
be	NULL
Ets-related	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

They	NULL
are	NULL
,	NULL
however	NULL
,	NULL
distinct	NULL
from	NULL
Ets-1	NULL
and	NULL
NF-AT/	NULL
Elf-1	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
differences	NULL
in	NULL
molecular	NULL
sizes	NULL
and	NULL
binding	NULL
specificities	NULL
of	NULL
the	NULL
proteins	NULL
bound	NULL
to	NULL
each	NULL
of	NULL
the	NULL
three	NULL
oligonucleotide	NULL
probes	NULL
encoding	NULL
the	NULL
NF-P	NULL
motif	NULL
and	NULL
the	NULL
putative	NULL
Ets-1	NULL
and	NULL
NF-AT/EIf-1-binding	NULL
sites	NULL
,	NULL
as	NULL
observed	NULL
for	NULL
CTLL-R8	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
YAC-1	NULL
,	NULL
EL-4	NULL
,	NULL
and	NULL
human	NULL
Jurkat	NULL
cells	NULL
(	NULL
17a	NULL
)	NULL
.	NULL

Considering	NULL
the	NULL
similarities	NULL
between	NULL
various	NULL
Ets-binding	NULL
sequences	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
Ets	NULL
family	NULL
members	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
Ets-1	NULL
oligonucleotide	NULL
tested	NULL
might	NULL
have	NULL
formed	NULL
complexes	NULL
with	NULL
other	NULL
Ets-related	NULL
proteins	NULL
,	NULL
instead	NULL
of	NULL
the	NULL
genuine	NULL
Ets-1	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
complexes	NULL
formed	NULL
with	NULL
different	NULL
oligonucleotide	NULL
probes	NULL
tested	NULL
,	NULL
therefore	NULL
,	NULL
does	NULL
not	NULL
necessarily	NULL
indicate	NULL
that	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
are	NULL
distinct	NULL
from	NULL
Ets-1	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
anti-Ets-1	NULL
or	NULL
anti-Ets-2	NULL
monoclonal	NULL
antibody	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
results	NULL
that	NULL
these	NULL
antibodies	NULL
neither	NULL
blocked	NULL
the	NULL
formation	NULL
of	NULL
B1-B2	NULL
with	NULL
OL-2	NULL
nor	NULL
induced	NULL
a	NULL
super-shift	NULL
of	NULL
B1-B2	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
,	NULL
it	NULL
appears	NULL
unlikely	NULL
that	NULL
either	NULL
NF-P1	NULL
or	NULL
NF-P2	NULL
is	NULL
identical	NULL
to	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
.	NULL

Given	NULL
the	NULL
complexity	NULL
and	NULL
the	NULL
widespread	NULL
nature	NULL
of	NULL
both	NULL
the	NULL
Ets-related	NULL
proteins	NULL
and	NULL
their	NULL
cognate	NULL
binding	NULL
sequences	NULL
,	NULL
proper	NULL
interaction	NULL
between	NULL
these	NULL
trans-and	NULL
cis-acting	NULL
elements	NULL
obviously	NULL
requires	NULL
certain	NULL
regula-tion	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
sequences	NULL
flanking	NULL
the	NULL
GGAA/T	NULL
core	NULL
play	NULL
a	NULL
role	NULL
in	NULL
controlling	NULL
the	NULL
specific	NULL
recognition	NULL
by	NULL
different	NULL
Ets	NULL
family	NULL
proteins	NULL
(	NULL
31	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Although	NULL
an	NULL
EBS-specific	NULL
probe	NULL
,	NULL
with	NULL
a	NULL
sequence	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
NF-P	NULL
motif	NULL
(	NULL
AgAGGAAGT	NULL
)	NULL
,	NULL
could	NULL
efficiently	NULL
bind	NULL
Ets-1	NULL
or	NULL
NF-AT/Elf-1	NULL
proteins	NULL
(	NULL
43	NULL
)	NULL
,	NULL
the	NULL
genuine	NULL
NF-P	NULL
motif	NULL
exhibited	NULL
low	NULL
or	NULL
virtually	NULL
no	NULL
affinity	NULL
for	NULL
Ets-1	NULL
and	NULL
NF-AT/EIf-1	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
5	NULL
'	NULL
end	NULL
and/or	NULL
the	NULL
flanking	NULL
nucleotides	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
discriminate	NULL
against	NULL
various	NULL
Ets	NULL
proteins	NULL
and	NULL
allow	NULL
only	NULL
the	NULL
specific	NULL
interaction	NULL
with	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
3'-end	NULL
residues	NULL
of	NULL
the	NULL
EBS	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
determining	NULL
the	NULL
specific	NULL
interaction	NULL
of	NULL
each	NULL
EBS	NULL
motif	NULL
with	NULL
its	NULL
corresponding	NULL
Ets	NULL
family	NULL
member	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Another	NULL
possible	NULL
controlling	NULL
mechanism	NULL
is	NULL
based	NULL
on	NULL
the	NULL
interaction	NULL
of	NULL
Ets	NULL
proteins	NULL
with	NULL
other	NULL
proteins	NULL
,	NULL
which	NULL
then	NULL
confers	NULL
the	NULL
specificity	NULL
of	NULL
binding	NULL
of	NULL
Ets	NULL
proteins	NULL
to	NULL
unique	NULL
EBSs	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Whether	NULL
this	NULL
protein-protein	NULL
interaction	NULL
also	NULL
determines	NULL
the	NULL
specific	NULL
binding	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
to	NULL
the	NULL
NF-P	NULL
motif	NULL
still	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
Ets-1	NULL
and	NULL
NF-AT/Elf-1	NULL
,	NULL
three	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
,	NULL
Ets-2	NULL
,	NULL
Fli-1	NULL
,	NULL
and	NULL
GABPa	NULL
,	NULL
are	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
2-4	NULL
,	NULL
19	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
also	NULL
seem	NULL
to	NULL
be	NULL
different	NULL
from	NULL
all	NULL
of	NULL
them	NULL
.	NULL

Ets-2	NULL
is	NULL
generally	NULL
thought	NULL
to	NULL
display	NULL
a	NULL
binding	NULL
specificity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
Ets-1	NULL
(	NULL
43	NULL
,	NULL
45	NULL
)	NULL
and	NULL
most	NULL
likely	NULL
is	NULL
distinct	NULL
from	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
anti-Ets-2	NULL
antibody	NULL
to	NULL
modify	NULL
the	NULL
migration	NULL
of	NULL
B1-B2	NULL
is	NULL
also	NULL
in	NULL
favor	NULL
of	NULL
this	NULL
conclusion	NULL
.	NULL

Fli-1	NULL
is	NULL
a	NULL
single-polypeptide	NULL
factor	NULL
(	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
appear	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
at	NULL
least	NULL
two	NULL
polypeptide	NULL
subunits	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

GABPa	NULL
,	NULL
which	NULL
forms	NULL
an	NULL
a	NULL
,	NULL
B	NULL
;	NULL
tetramer	NULL
with	NULL
the	NULL
non-DNA-binding	NULL
subunit	NULL
GABPRG	NULL
(	NULL
19	NULL
,	NULL
39	NULL
)	NULL
,	NULL
possesses	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
51	NULL
kDa	NULL
,	NULL
which	NULL
is	NULL
significantly	NULL
different	NULL
from	NULL
those	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
Fli-1	NULL
and	NULL
GABPa	NULL
are	NULL
reported	NULL
to	NULL
be	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
constitutively	NULL
expressed	NULL
in	NULL
thymus	NULL
and	NULL
spleen	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
19	NULL
,	NULL
39	NULL
)	NULL
,	NULL
while	NULL
NF-P2	NULL
seems	NULL
to	NULL
be	NULL
induced	NULL
only	NULL
upon	NULL
cell	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
the	NULL
expression	NULL
of	NULL
Fli-1	NULL
and	NULL
GABPa	NULL
will	NULL
be	NULL
further	NULL
up-regulated	NULL
upon	NULL
cell	NULL
activation	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
conclude	NULL
that	NULL
,	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
characteristics	NULL
discussed	NULL
above	NULL
,	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
are	NULL
distinct	NULL
from	NULL
either	NULL
Fli-1	NULL
or	NULL
GABPa	NULL
.	NULL

The	NULL
definite	NULL
identities	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
,	NULL
nonetheless	NULL
,	NULL
can	NULL
be	NULL
resolved	NULL
only	NULL
when	NULL
the	NULL
amino	NULL
acid	NULL
or	NULL
cDNA	NULL
sequences	NULL
of	NULL
these	NULL
proteins	NULL
become	NULL
available	NULL
.	NULL

|	NULL
EBS	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
different	NULL
promoters/enhancers	NULL
of	NULL
different	NULL
viral	NULL
and	NULL
mammalian	NULL
genes	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
transcription	NULL
of	NULL
these	NULL
genes	NULL
often	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
Ets-related	NULL
proteins	NULL
.	NULL

Most	NULL
known	NULL
mammalian	NULL
Ets	NULL
family	NULL
members	NULL
are	NULL
expressed	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
and	NULL
presumably	NULL
contribute	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
cell-	NULL
or	NULL
tissue-specific	NULL
gene	NULL
transcription	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
Ets-1	NULL
and	NULL
NF-AT/EIf-1	NULL
are	NULL
preferentially	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
36	NULL
,	NULL
38	NULL
)	NULL
;	NULL
PU.1	NULL
is	NULL
expressed	NULL
in	NULL
macrophage	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
;	NULL
elk-	NULL
]	NULL
is	NULL
expressed	NULL
in	NULL
lung	NULL
and	NULL
testis	NULL
(	NULL
34	NULL
)	NULL
;	NULL
and	NULL
PEA	NULL
3	NULL
is	NULL
expressed	NULL
in	NULL
epididymis	NULL
and	NULL
brain	NULL
tissue	NULL
(	NULL
46	NULL
)	NULL
.	NULL

NF-P2	NULL
identified	NULL
in	NULL
the	NULL
present	NULL
study	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
novel	NULL
killer	NULL
cell-specific	NULL
Ets-related	NULL
protein	NULL
.	NULL

Although	NULL
the	NULL
biological	NULL
function	NULL
of	NULL
this	NULL
factor	NULL
remains	NULL
somewhat	NULL
obscure	NULL
,	NULL
two	NULL
lines	NULL
of	NULL
evidence	NULL
support	NULL
the	NULL
role	NULL
of	NULL
NF-P2	NULL
as	NULL
a	NULL
killer	NULL
cell-specific	NULL
activator	NULL
for	NULL
mouse	NULL
Pfp	NULL
.	NULL

Firstly	NULL
,	NULL
NF-P2	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
lymphocytes	NULL
with	NULL
a	NULL
killer	NULL
phenotype	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
could	NULL
be	NULL
modulated	NULL
by	NULL
reagents	NULL
known	NULL
to	NULL
activate	NULL
T	NULL
cells	NULL
and	NULL
up-regulate	NULL
perforin	NULL
message	NULL
levels	NULL
.	NULL

Secondly	NULL
,	NULL
the	NULL
NF-P	NULL
motif	NULL
to	NULL
which	NULL
NF-P2	NULL
binds	NULL
was	NULL
capable	NULL
of	NULL
enhancing	NULL
gene	NULL
expression	NULL
when	NULL
the	NULL
particular	NULL
reporter	NULL
construct	NULL
(	NULL
pCAT	NULL
.	NULL

,	NULL
,	NULL
;	NULL
,	NULL
,	NULL
)	NULL
was	NULL
transiently	NULL
expressed	NULL
in	NULL
CTLL-R8	NULL
but	NULL
not	NULL
in	NULL
EL-4	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

That	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
pCAT	NULL
,	NULL
,	NULL
;	NULL
,	NULL
,	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
a	NULL
greater	NULL
CAT	NULL
expression	NULL
driven	NULL
by	NULL
pCAT_	NULL
;	NULL
4	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
implies	NULL
that	NULL
the	NULL
NF-P	NULL
motif	NULL
is	NULL
not	NULL
the	NULL
only	NULL
positive	NULL
regulatory	NULL
element	NULL
present	NULL
within	NULL
that	NULL
region	NULL
of	NULL
Pfp	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
sequences	NULL
homologous	NULL
to	NULL
the	NULL
AP-1-	NULL
and	NULL
AP-2-binding	NULL
sites	NULL
were	NULL
also	NULL
identified	NULL
near	NULL
the	NULL
NF-P	NULL
motif	NULL
in	NULL
the	NULL
-flanking	NULL
region	NULL
of	NULL
mouse	NULL
Pfp	NULL
.	NULL

Precedents	NULL
showing	NULL
that	NULL
Ets	NULL
proteins	NULL
interact	NULL
with	NULL
AP-1	NULL
and/or	NULL
other	NULL
transcription	NULL
factors	NULL
so	NULL
as	NULL
to	NULL
become	NULL
functionally	NULL
active	NULL
have	NULL
been	NULL
reported	NULL
(	NULL
9	NULL
,	NULL
26	NULL
,	NULL
28	NULL
,	NULL
33	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
,	NULL
for	NULL
Pfp	NULL
,	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
also	NULL
play	NULL
a	NULL
regulatory	NULL
role	NULL
by	NULL
cooperating	NULL
with	NULL
proteins	NULL
bound	NULL
to	NULL
either	NULL
the	NULL
other	NULL
regulatory	NULL
elements	NULL
or	NULL
the	NULL
basal	NULL
promoter	NULL
,	NULL
thereby	NULL
suppressing	NULL
or	NULL
initiating	NULL
the	NULL
gene	NULL
expression	NULL
in	NULL
perforin-negative	NULL
or	NULL
perforin-positive	NULL
cells	NULL
.	NULL

Since	NULL
NF-P1	NULL
was	NULL
found	NULL
to	NULL
be	NULL
present	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
examined	NULL
,	NULL
it	NULL
may	NULL
simply	NULL
bind	NULL
to	NULL
the	NULL
NF-P	NULL
motif	NULL
and	NULL
hence	NULL
prevent	NULL
the	NULL
subsequent	NULL
binding	NULL
or	NULL
interaction	NULL
of	NULL
other	NULL
factors	NULL
which	NULL
,	NULL
together	NULL
with	NULL
NF-P2	NULL
,	NULL
would	NULL
form	NULL
an	NULL
active	NULL
transcription	NULL
machinery	NULL
.	NULL

Upon	NULL
activation	NULL
of	NULL
the	NULL
killer	NULL
cells	NULL
,	NULL
NF-P1	NULL
may	NULL
either	NULL
be	NULL
displaced	NULL
or	NULL
replaced	NULL
by	NULL
NF-P2	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
be	NULL
transformed	NULL
into	NULL
NF-P2	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
;	NULL
see	NULL
below	NULL
)	NULL
,	NULL
which	NULL
then	NULL
assembles	NULL
into	NULL
the	NULL
effective	NULL
transcription	NULL
machinery	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
NF-P1	NULL
could	NULL
directly	NULL
suppress	NULL
the	NULL
basal	NULL
and	NULL
inducible	NULL
transcription	NULL
of	NULL
Pfp	NULL
in	NULL
non-CTLs	NULL
and	NULL
resting	NULL
CTLs	NULL
,	NULL
much	NULL
like	NULL
what	NULL
ETs-1	NULL
does	NULL
to	NULL
the	NULL
T-cell	NULL
receptor-B	NULL
gene	NULL
(	NULL
25	NULL
)	NULL
,	NULL
still	NULL
can	NULL
not	NULL
be	NULL
ruled	NULL
out	NULL
.	NULL

The	NULL
precise	NULL
functions	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
,	NULL
therefore	NULL
,	NULL
await	NULL
clarification	NULL
through	NULL
further	NULL
in	NULL
vitro	NULL
transcription	NULL
assays	NULL
with	NULL
the	NULL
purified	NULL
proteins	NULL
.	NULL

The	NULL
possibility	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
as	NULL
a	NULL
killer	NULL
cell-specific	NULL
regulatory	NULL
element	NULL
for	NULL
Pfp	NULL
is	NULL
further	NULL
strengthened	NULL
by	NULL
sequence	NULL
comparison	NULL
with	NULL
human	NULL
Pfp	NULL
.	NULL

The	NULL
NF-P	NULL
motif	NULL
and	NULL
its	NULL
flanking	NULL
region	NULL
are	NULL
found	NULL
to	NULL
be	NULL
also	NULL
well	NULL
conserved	NULL
in	NULL
the	NULL
human	NULL
gene	NULL
.	NULL

The	NULL
sequence	NULL
between	NULL
residues	NULL
-634	NULL
and	NULL
-604	NULL
of	NULL
human	NULL
Pfp	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
KILLER	NULL
CELL-SPECIFIC	NULL
REGULATORY	NULL
ELEMENT	NULL
OF	NULL
MOUSE	NULL
Pfp	NULL
6699	NULL
n	NULL
NF-P	NULL
CTL	NULL
activation	NULL
L.	NULL
lam	NULL
_L	NULL
L	NULL
)	NULL
:	NULL
-	NULL
'	NULL
Â¥	NULL
co	NULL
LC	NULL
A	NULL
CTL	NULL
activation	NULL
=	NULL
08	NULL
co	NULL
}	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Hypothetical	NULL
models	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
NF-P	NULL
motif	NULL
and	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
in	NULL
cell-specific	NULL
transcription	NULL
of	NULL
mouse	NULL
Pfp	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Upon	NULL
activation	NULL
,	NULL
NF-P1	NULL
,	NULL
which	NULL
originally	NULL
occupies	NULL
the	NULL
NF-P	NULL
motif	NULL
and	NULL
prevents	NULL
other	NULL
transcription	NULL
factors	NULL
from	NULL
binding	NULL
to	NULL
the	NULL
nearby	NULL
regulatory	NULL
elements	NULL
,	NULL
may	NULL
be	NULL
expelled	NULL
.	NULL

NF-P2	NULL
and	NULL
other	NULL
factors	NULL
are	NULL
now	NULL
allowed	NULL
to	NULL
access	NULL
the	NULL
DNA	NULL
and	NULL
initiate	NULL
efficient	NULL
transcription	NULL
in	NULL
a	NULL
cooperative	NULL
fashion	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
non-DNA-binding	NULL
subunits	NULL
which	NULL
block	NULL
the	NULL
binding	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
are	NULL
released	NULL
from	NULL
the	NULL
NF-P1	NULL
complex	NULL
upon	NULL
activation	NULL
.	NULL

The	NULL
trimmed	NULL
NF-P2	NULL
interacts	NULL
with	NULL
the	NULL
other	NULL
transcription	NULL
factor	NULL
and	NULL
enhances	NULL
transcription	NULL
.	NULL

O	NULL
,	NULL
[	NULL
I	NULL
,	NULL
A	NULL
,	NULL
and	NULL
Z7	NULL
,	NULL
putative	NULL
transcription	NULL
fac-tors	NULL
;	NULL
--	NULL
-	NULL
,	NULL
putative	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
;	NULL
+1	NULL
,	NULL
transcription	NULL
initiation	NULL
site	NULL
;	NULL
(	NULL
,	NULL
gene	NULL
transcription	NULL
.	NULL

the	NULL
mouse	NULL
sequence	NULL
between	NULL
residues	NULL
-522	NULL
and	NULL
-491	NULL
(	NULL
with	NULL
a	NULL
27	NULL
of	NULL
32	NULL
bases	NULL
identity	NULL
)	NULL
.	NULL

Sequence	NULL
comparison	NULL
showed	NULL
that	NULL
the	NULL
human	NULL
NF-P	NULL
motif	NULL
counterpart	NULL
resides	NULL
between	NULL
residues	NULL
-618	NULL
and	NULL
-610	NULL
,	NULL
consisting	NULL
of	NULL
5'-gCAGGAAGT	NULL
(	NULL
with	NULL
an	NULL
eight	NULL
of	NULL
nine	NULL
bases	NULL
identify	NULL
to	NULL
the	NULL
mouse	NULL
NF-P	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
this	NULL
,	NULL
it	NULL
is	NULL
postulated	NULL
that	NULL
the	NULL
highly	NULL
conserved	NULL
NF-P	NULL
motif	NULL
should	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
perforin	NULL
gene	NULL
expression	NULL
.	NULL

Systematic	NULL
mutational	NULL
analysis	NULL
addressing	NULL
the	NULL
precise	NULL
function	NULL
of	NULL
this	NULL
motif	NULL
and	NULL
its	NULL
relationship	NULL
with	NULL
other	NULL
potential	NULL
regulatory	NULL
elements	NULL
in	NULL
controlling	NULL
killer	NULL
cell-specific	NULL
Pfp	NULL
expression	NULL
is	NULL
currently	NULL
being	NULL
performed	NULL
.	NULL

With	NULL
respect	NULL
to	NULL
the	NULL
molecular	NULL
structure	NULL
of	NULL
NF-P1	NULL
and	NULL
NF-P2	NULL
,	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
revealed	NULL
that	NULL
the	NULL
two	NULL
factors	NULL
contained	NULL
similar-size	NULL
DNA-binding	NULL
subunits	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

NF-P1	NULL
,	NULL
however	NULL
,	NULL
had	NULL
a	NULL
higher	NULL
native	NULL
molecular	NULL
mass	NULL
than	NULL
NF-P2	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

This	NULL
difference	NULL
in	NULL
molecular	NULL
mass	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
an	NULL
additional	NULL
NF-Pl-specific	NULL
6700	NULL
KOIZUMI	NULL
ET	NULL
AL	NULL
.	NULL

protein	NULL
component	NULL
(	NULL
s	NULL
)	NULL
that	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
.	NULL

The	NULL
postulated	NULL
non-DNA-binding	NULL
subunit	NULL
(	NULL
s	NULL
)	NULL
,	NULL
however	NULL
,	NULL
may	NULL
be	NULL
in	NULL
close	NULL
proximity	NULL
to	NULL
DNA	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
from	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
revealed	NULL
that	NULL
two	NULL
high-molecular-weight	NULL
species	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
dominant	NULL
common	NULL
subunits	NULL
,	NULL
were	NULL
eluted	NULL
from	NULL
Bl	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
different	NULL
subunits	NULL
of	NULL
NF-P1	NULL
might	NULL
have	NULL
been	NULL
cross-linked	NULL
together	NULL
and	NULL
migrated	NULL
as	NULL
undissociated	NULL
complexes	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDS	NULL
and	NULL
reducing	NULL
agent	NULL
.	NULL

This	NULL
kind	NULL
of	NULL
close	NULL
spatial	NULL
relationship	NULL
which	NULL
leads	NULL
to	NULL
cross-linking	NULL
of	NULL
the	NULL
non-DNA-binding	NULL
unit	NULL
to	NULL
DNA	NULL
has	NULL
previously	NULL
been	NULL
reported	NULL
for	NULL
GABP	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Cross-linking	NULL
of	NULL
two	NULL
proteins	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
adjacent	NULL
DNA-binding	NULL
sequences	NULL
,	NULL
forming	NULL
an	NULL
SDS-resistant	NULL
complex	NULL
,	NULL
has	NULL
been	NULL
observed	NULL
for	NULL
PU.1	NULL
and	NULL
its	NULL
axillary	NULL
factor	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
NF-P1	NULL
is	NULL
an	NULL
alternative	NULL
and	NULL
inactive	NULL
form	NULL
of	NULL
NF-P2	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
our	NULL
recent	NULL
finding	NULL
that	NULL
NF-P1	NULL
may	NULL
be	NULL
converted	NULL
into	NULL
NF-P2	NULL
upon	NULL
treatment	NULL
with	NULL
denaturing	NULL
agents	NULL
such	NULL
as	NULL
SDS	NULL
plus	NULL
Nonidet	NULL
P-40	NULL
or	NULL
guani-dine	NULL
hydrochloride	NULL
(	NULL
13a	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
model	NULL
has	NULL
recently	NULL
been	NULL
proposed	NULL
for	NULL
the	NULL
pancreas-specific	NULL
transcription	NULL
factor	NULL
PTF1	NULL
,	NULL
in	NULL
which	NULL
the	NULL
nuclear	NULL
form	NULL
PTFla	NULL
differs	NULL
from	NULL
the	NULL
cytoplasmic	NULL
form	NULL
B	NULL
by	NULL
an	NULL
additional	NULL
protein	NULL
component	NULL
which	NULL
lacks	NULL
the	NULL
DNA-binding	NULL
activity	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
cell	NULL
stimulations	NULL
result	NULL
in	NULL
the	NULL
release	NULL
of	NULL
the	NULL
additional	NULL
subunit	NULL
(	NULL
s	NULL
)	NULL
from	NULL
NF-P1	NULL
exclusively	NULL
in	NULL
killer	NULL
lymphocytes	NULL
for	NULL
reasons	NULL
as	NULL
yet	NULL
unclear	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
the	NULL
additional	NULL
subunit	NULL
(	NULL
s	NULL
)	NULL
may	NULL
result	NULL
in	NULL
the	NULL
conversion	NULL
of	NULL
NF-P1	NULL
(	NULL
transcriptionally	NULL
inactive	NULL
)	NULL
into	NULL
NF-P2	NULL
(	NULL
transcriptionally	NULL
ac-tive	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

This	NULL
postulation	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
B1-B2	NULL
modulation	NULL
observed	NULL
in	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
since	NULL
the	NULL
hypothetical	NULL
conversion	NULL
should	NULL
lead	NULL
to	NULL
the	NULL
decrease	NULL
of	NULL
NF-P1	NULL
and	NULL
the	NULL
increase	NULL
of	NULL
NF-P2	NULL
,	NULL
which	NULL
were	NULL
indeed	NULL
observed	NULL
.	NULL

In	NULL
vitro	NULL
reconstitution	NULL
and	NULL
dissociation	NULL
analyses	NULL
are	NULL
being	NULL
carried	NULL
out	NULL
to	NULL
further	NULL
test	NULL
this	NULL
hypothesis	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Z	NULL
.	NULL

A.	NULL
Cohn	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
for	NULL
constant	NULL
support	NULL
and	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
acknowledge	NULL
A.	NULL
Granelli-Piperno	NULL
for	NULL
providing	NULL
the	NULL
NF-AT/EIf-1	NULL
oligonucleotide	NULL
and	NULL
nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
and	NULL
for	NULL
helpful	NULL
discussion	NULL
,	NULL
and	NULL
K.	NULL
Barker	NULL
and	NULL
G.	NULL
Kaplan	NULL
for	NULL
reading	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
CA-47307	NULL
to	NULL
J.D.-E.Y	NULL
.	NULL

and	NULL
RO3-DE10525	NULL
to	NULL
B.S.K	NULL
.	NULL
)	NULL

,	NULL
American	NULL
Cancer	NULL
Society	NULL
(	NULL
CH425	NULL
)	NULL
,	NULL
and	NULL
American	NULL
Heart	NULL
Association	NULL
,	NULL
New	NULL
York	NULL
City	NULL
Affiliate	NULL
.	NULL

M.F.H	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
the	NULL
National	NULL
Research	NULL
Council	NULL
(	NULL
CNPq	NULL
)	NULL
-Brazil	NULL
and	NULL
the	NULL
Fogarty	NULL
International	NULL
Center	NULL
(	NULL
NIH	NULL
)	NULL
.	NULL

J.D.-E.Y	NULL
.	NULL

is	NULL
a	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

C.-C.L	NULL
.	NULL

is	NULL
currently	NULL
supported	NULL
by	NULL
an	NULL
Investi-gatorship	NULL
from	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
,	NULL
New	NULL
York	NULL
City	NULL
Affiliate	NULL
,	NULL
and	NULL
by	NULL
a	NULL
Hirschl	NULL
Career	NULL
Scientist	NULL
Award	NULL
.	NULL

B.S.K	NULL
.	NULL

is	NULL
also	NULL
supported	NULL
by	NULL
a	NULL
fund	NULL
from	NULL
The	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Seoul	NULL
National	NULL
University	NULL
,	NULL
Seoul	NULL
,	NULL
Republic	NULL
of	NULL
Korea	NULL
(	NULL
KOSEF-SRC-56-CRC-21	NULL
)	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Abken	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
B.	NULL
Reifenrath	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
procedure	NULL
to	NULL
standardize	NULL
CAT	NULL
reporter	NULL
gene	NULL
assay	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:3527	NULL
.	NULL

2	NULL
.	NULL

Ben-David	NULL
,	NULL
Y.	NULL
,	NULL
E.	NULL
B.	NULL
Giddens	NULL
,	NULL
K.	NULL
Letwin	NULL
,	NULL
and	NULL
A.	NULL
Bernstein	NULL
.	NULL

1991	NULL
.	NULL

Erythroleukemia	NULL
induction	NULL
by	NULL
Friend	NULL
murine	NULL
leukemia	NULL
virus	NULL
:	NULL
insertional	NULL
activation	NULL
of	NULL
a	NULL
new	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
gene	NULL
family	NULL
,	NULL
Fli-1	NULL
,	NULL
closely	NULL
linked	NULL
to	NULL
c-ets-1	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:908-918	NULL
.	NULL

3	NULL
.	NULL

Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
S.	NULL
Fujiwara	NULL
,	NULL
R.	NULL
Ascione	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1987	NULL
.	NULL

Temporal	NULL
and	NULL
tissue-specific	NULL
expression	NULL
of	NULL
mouse	NULL
ets	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:3161-3165	NULL
.	NULL

4	NULL
.	NULL

Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
K.	NULL
L.	NULL
Komschlies	NULL
,	NULL
S.	NULL
Fujiwara	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
B.	NULL
J.	NULL
Mathieson	NULL
,	NULL
T.	NULL
A.	NULL
Gregorio	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
J.	NULL
W.	NULL
Kasik	NULL
,	NULL
K.	NULL
Ozato	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
ets	NULL
genes	NULL
in	NULL
mouse	NULL
thymocyte	NULL
subsets	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:672-678	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

5	NULL
.	NULL

Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
and	NULL
uses	NULL
of	NULL
monoclonal	NULL
antibody	NULL
derived	NULL
against	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
of	NULL
genes	NULL
.	NULL

Hybridoma	NULL
11:277-294	NULL
.	NULL

6	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72:248-254	NULL
.	NULL

7	NULL
.	NULL

Brown	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1992	NULL
.	NULL

Specificities	NULL
of	NULL
protein-protein	NULL
and	NULL
protein-DNA	NULL
interaction	NULL
of	NULL
GABPa	NULL
and	NULL
two	NULL
newly	NULL
defined	NULL
ets-related	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2502-2512	NULL
.	NULL

8	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

9	NULL
.	NULL

Dudek	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
V.	NULL
Tantravahi	NULL
,	NULL
V.	NULL
N.	NULL
Rao	NULL
,	NULL
E.	NULL
S.	NULL
Reddy	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
Reddy	NULL
.	NULL

1992	NULL
.	NULL

Myb	NULL
and	NULL
Ets	NULL
proteins	NULL
cooperate	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
mim-1	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1291-1295	NULL
.	NULL

10	NULL
.	NULL

Gibbons	NULL
,	NULL
I.	NULL
R.	NULL
,	NULL
A.	NULL
Lee-Eiford	NULL
,	NULL
G.	NULL
Mocz	NULL
,	NULL
C.	NULL
A.	NULL
Phillipson	NULL
,	NULL
W.-J	NULL
.	NULL

Tang	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Giobbons	NULL
.	NULL

1987	NULL
.	NULL

Photosensitized	NULL
cleavage	NULL
of	NULL
dynein	NULL
heavy	NULL
chains	NULL
.	NULL

Cleavage	NULL
at	NULL
the	NULL
``	NULL
V1	NULL
site	NULL
``	NULL
by	NULL
irradiation	NULL
at	NULL
365	NULL
nm	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ATP	NULL
and	NULL
vanadate	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262:2780-2786	NULL
.	NULL

11	NULL
.	NULL

Gorski	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Carneiro	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1986	NULL
.	NULL

Tissue-specific	NULL
in	NULL
vitro	NULL
transcription	NULL
from	NULL
the	NULL
mouse	NULL
albumin	NULL
promoter	NULL
.	NULL

Cell	NULL
47:767-776	NULL
.	NULL

12	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
P.	NULL
McHugh	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
protein	NULL
that	NULL
regulates	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-AT	NULL
,	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:11431-11434	NULL
.	NULL

13	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
N.-H.	NULL
Bhat	NULL
,	NULL
L.	NULL
R.	NULL
Gottschalk	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
binding	NULL
of	NULL
human	NULL
Ets-1	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
alpha	NULL
gene	NULL
enhancer	NULL
.	NULL

Science	NULL
250:814-818	NULL
.	NULL

13a.Horta	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

14	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
356:801-804	NULL
.	NULL

15	NULL
.	NULL

Joag	NULL
,	NULL
S.	NULL
V.	NULL
,	NULL
C.-C.	NULL
Liu	NULL
,	NULL
B.	NULL
S.	NULL
Kwon	NULL
,	NULL
W.	NULL
R.	NULL
Clark	NULL
,	NULL
and	NULL
J.	NULL
D.-E.	NULL
Young	NULL
.	NULL

1990	NULL
.	NULL

Expression	NULL
of	NULL
mRNAs	NULL
for	NULL
pore-forming	NULL
proteins	NULL
and	NULL
two	NULL
serine	NULL
esterases	NULL
in	NULL
murine	NULL
primary	NULL
and	NULL
cloned	NULL
effector	NULL
lymphocytes	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

43:81-88	NULL
.	NULL

16	NULL
.	NULL

Karim	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
L.	NULL
D.	NULL
Urness	NULL
,	NULL
C.	NULL
S.	NULL
Thummel	NULL
,	NULL
M.	NULL
J.	NULL
Klemsz	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
V.	NULL
Beveren	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
ETS-domain	NULL
:	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
that	NULL
recognize	NULL
a	NULL
purine-rich	NULL
core	NULL
DNA	NULL
sequence	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1451-1453	NULL
.	NULL

17	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
V.	NULL
Beveren	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Maki	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
61:113-124	NULL
.	NULL

17a.Koizumi	NULL
,	NULL
H.	NULL
Unpublished	NULL
data	NULL
.	NULL

18	NULL
.	NULL

Koizumi	NULL
,	NULL
H.	NULL
,	NULL
C.-C.	NULL
Liu	NULL
,	NULL
L.	NULL
M.	NULL
Zheng	NULL
,	NULL
S.	NULL
V.	NULL
Joag	NULL
,	NULL
N.	NULL
K.	NULL
Bayne	NULL
,	NULL
J.	NULL
Holoshitz	NULL
,	NULL
and	NULL
J.	NULL
D.-E.	NULL
Young	NULL
.	NULL

1991	NULL
.	NULL

Expression	NULL
of	NULL
perforin	NULL
and	NULL
serine	NULL
esterases	NULL
by	NULL
human	NULL
gamma/delta	NULL
T-cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:499-502	NULL
.	NULL

19	NULL
.	NULL

LaMarco	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
C.	NULL
Thompson	NULL
,	NULL
B.	NULL
P.	NULL
Byers	NULL
,	NULL
E.	NULL
M.	NULL
Waiton	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
Ets-	NULL
and	NULL
Notch-related	NULL
subunits	NULL
in	NULL
GA	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
253:789-792	NULL
.	NULL

20	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
1992	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
during	NULL
T-cell	NULL
development	NULL
:	NULL
the	NULL
alpha	NULL
TCR	NULL
gene	NULL
as	NULL
a	NULL
molecular	NULL
model	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:22-30	NULL
.	NULL

21	NULL
.	NULL

Lichtenheld	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
E.	NULL
R.	NULL
Podack	NULL
.	NULL

1989	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
human	NULL
perforin	NULL
gene	NULL
.	NULL

A	NULL
simple	NULL
gene	NULL
organization	NULL
with	NULL
interesting	NULL
potential	NULL
regulatory	NULL
sequences	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143	NULL
;	NULL
:4267-4274	NULL
.	NULL

22	NULL
.	NULL

Lichtenheld	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
E.	NULL
R.	NULL
Podack	NULL
.	NULL

1992	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
murine	NULL
perforin	NULL
promoter	NULL
and	NULL
upstream	NULL
region	NULL
:	NULL
reciprocal	NULL
gene	NULL
activation	NULL
or	NULL
silencing	NULL
in	NULL
perforin	NULL
positive	NULL
and	NULL
negative	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:2619-2626	NULL
.	NULL

23	NULL
.	NULL

Liu	NULL
,	NULL
C.-C.	NULL
,	NULL
S.	NULL
V.	NULL
Joag	NULL
,	NULL
B.	NULL
S.	NULL
Kwon	NULL
,	NULL
and	NULL
J.	NULL
D.-E.	NULL
Young	NULL
.	NULL

1990	NULL
.	NULL

Induction	NULL
of	NULL
perforin	NULL
and	NULL
serine	NULL
esterases	NULL
in	NULL
a	NULL
murine	NULL
cytotoxic	NULL
T	NULL
lymphocyte	NULL
clone	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:1196-1201	NULL
.	NULL

24	NULL
.	NULL

Lin	NULL
,	NULL
C.-C.	NULL
,	NULL
S.	NULL
Rafi	NULL
,	NULL
A.	NULL
Granelli-Piperno	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Trapani	NULL
,	NULL
and	NULL
J.	NULL
D.-E.	NULL
Young	NULL
.	NULL

1989	NULL
.	NULL

Perforin	NULL
and	NULL
serine	NULL
esterase	NULL
gene	NULL
expression	NULL
in	NULL
stimulated	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
kinetics	NULL
,	NULL
mitogen	NULL
require	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37.	NULL
ments	NULL
,	NULL
and	NULL
effect	NULL
of	NULL
cyclosporin	NULL
A.	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170:2105-2118.	NULL
.	NULL

Macleod	NULL
,	NULL
K.	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17:251-256	NULL
.	NULL

Majerus	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
F.	NULL
Bibollet-Ruche	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Telliez	NULL
,	NULL
B.	NULL
Wasylyk	NULL
,	NULL
and	NULL
B.	NULL
Bailleul	NULL
.	NULL

1992	NULL
.	NULL

Serum	NULL
,	NULL
AP-1	NULL
and	NULL
Ets-1	NULL
stimulate	NULL
the	NULL
human	NULL
ets-1	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:2699-2703	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Goodbourn	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Fischer	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
236	NULL
:	NULL
1237-1244.	NULL
.	NULL

Mavrothalassitis	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1991	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
factors	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
ETS2	NULL
gene	NULL
via	NULL
an	NULL
oncogene-responsive-like	NULL
unit	NULL
within	NULL
the	NULL
ETS2	NULL
promoter	NULL
region	NULL
.	NULL

Cell	NULL
Growth	NULL
Diff	NULL
.	NULL

2:215-224	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
245:371-378	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

NF-	NULL
Â«	NULL
B	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:10028-10032	NULL
.	NULL

Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
M.	NULL
Pertersin	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
M.	NULL
D.	NULL
Jonsen	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
murine	NULL
Ets-1	NULL
with	NULL
GGA-binding	NULL
sites	NULL
establishes	NULL
the	NULL
ETS	NULL
domain	NULL
as	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:975-990	NULL
.	NULL

Podack	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
H.	NULL
Hegartner	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Lichtenheld	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
central	NULL
role	NULL
of	NULL
perforin	NULL
in	NULL
cytolysis	NULL
?	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9:129-157	NULL
.	NULL

Pongubala	NULL
,	NULL
J.	NULL
M.	NULL
R.	NULL
,	NULL
S.	NULL
Nagulapalli	NULL
,	NULL
M.	NULL
J.	NULL
Klemsz	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Atchison	NULL
.	NULL

1992	NULL
.	NULL

PU.1	NULL
recruits	NULL
a	NULL
second	NULL
nuclear	NULL
factor	NULL
to	NULL
a	NULL
site	NULL
important	NULL
for	NULL
immunoglobulin	NULL
k	NULL
3	NULL
'	NULL
enhancer	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:368-378	NULL
.	NULL

Rao	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
K.	NULL
Huebner	NULL
,	NULL
M.	NULL
Isobe	NULL
,	NULL
A.	NULL
Ar-Rushdi	NULL
,	NULL
C.	NULL
M.	NULL
Croce	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
S.	NULL
Reddy	NULL
.	NULL

1989.	NULL
e/k	NULL
,	NULL
tissue-specific	NULL
ets-related	NULL
genes	NULL
on	NULL
chromosomes	NULL
X	NULL
and	NULL
14	NULL
near	NULL
translocation	NULL
breakpoints	NULL
.	NULL

Science	NULL
244:66-70	NULL
.	NULL

Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Cromlish	NULL
,	NULL
T.	NULL
Gerster	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
C.-G.	NULL
Balmaceda	NULL
,	NULL
R.	NULL
A.	NULL
Currie	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
human	NULL
lymphoid-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
immunoglobulin	NULL
genes	NULL
is	NULL
a	NULL
homeobox	NULL
protein	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
336	NULL
:	NULL
551-557	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202-205	NULL
.	NULL

Sommer	NULL
,	NULL
L.	NULL
,	NULL
O.	NULL
Hagenbuchle	NULL
,	NULL
P.	NULL
K.	NULL
Wellauer	NULL
,	NULL
and	NULL
M.	NULL
Strubin	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
targeting	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
PTFl	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
protein	NULL
subunit	NULL
that	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
PTF1L	NULL
KILLER	NULL
CELL-SPECIFIC	NULL
REGULATORY	NULL
ELEMENT	NULL
OF	NULL
MOUSE	NULL
Pfp	NULL
38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

49	NULL
.	NULL

6701	NULL
cognate	NULL
sequence	NULL
.	NULL

Cell	NULL
67:987-994	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
P.	NULL
R.	NULL
Bohjanen	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Miesfeldt	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
B.	NULL
Karpinski	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992.	NULL
cis-acting	NULL
sequence	NULL
required	NULL
for	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
Ets-related	NULL
protein	NULL
,	NULL
Elf-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1043-1053	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Convergence	NULL
of	NULL
ets-	NULL
and	NULL
notch-related	NULL
structural	NULL
motifs	NULL
in	NULL
a	NULL
heteromeric	NULL
DNA-binding	NULL
complex	NULL
.	NULL

Science	NULL
153:762-768.	NULL
.	NULL

Trapani	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
B.	NULL
Dupont	NULL
.	NULL

1990	NULL
.	NULL

Novel	NULL
putative	NULL
promoter/	NULL
enhancer	NULL
sequences	NULL
are	NULL
shared	NULL
by	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
perforin	NULL
gene	NULL
.	NULL

Tissue	NULL
Antigens	NULL
36:228-234	NULL
.	NULL

Trapani	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
B.	NULL
S.	NULL
Kwon	NULL
,	NULL
C.	NULL
A.	NULL
Kozak	NULL
,	NULL
C.	NULL
Chintamaneni	NULL
,	NULL
J.	NULL
D.-E.	NULL
Young	NULL
,	NULL
and	NULL
B.	NULL
Dupont	NULL
.	NULL

1990	NULL
.	NULL

Genomic	NULL
organization	NULL
of	NULL
the	NULL
pore-forming	NULL
protein	NULL
(	NULL
perforin	NULL
)	NULL
gene	NULL
and	NULL
localization	NULL
to	NULL
chromosome	NULL
10	NULL
:	NULL
similarities	NULL
to	NULL
and	NULL
differences	NULL
from	NULL
C9	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:545-557	NULL
.	NULL

Tschopp	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1990	NULL
.	NULL

Perforin-mediated	NULL
target	NULL
cell	NULL
lysis	NULL
by	NULL
cytolytic	NULL
T	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:279-302	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
B.	NULL
Petryniak	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992	NULL
.	NULL

Evolutionarily	NULL
conserved	NULL
Ets	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
:	NULL
1391-1399.	NULL
.	NULL

Watson	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
R.	NULL
Ascione	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
Ets	NULL
genes	NULL
and	NULL
their	NULL
products	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Oncog	NULL
.	NULL

1:409-436	NULL
.	NULL

Woods	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
nucleotide	NULL
preferences	NULL
in	NULL
DNA	NULL
sequences	NULL
recognised	NULL
specifically	NULL
by	NULL
c-Ets-1	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

4:699-704.	NULL
.	NULL

Xin	NULL
,	NULL
J.-H.	NULL
,	NULL
A.	NULL
Cowie	NULL
,	NULL
P.	NULL
Lachance	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Hassell	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
PEA3	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
oncogene	NULL
family	NULL
that	NULL
is	NULL
differentially	NULL
expressed	NULL
in	NULL
mouse	NULL
embryonic	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:481-496	NULL
.	NULL

Youn	NULL
,	NULL
B.-S.	NULL
,	NULL
C.-C.	NULL
Liu	NULL
,	NULL
K.-K.	NULL
Kim	NULL
,	NULL
J.	NULL
D.-E.	NULL
Young	NULL
,	NULL
M.	NULL
H.	NULL
Kwon	NULL
,	NULL
and	NULL
B.	NULL
S.	NULL
Kwon	NULL
.	NULL

1991	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
mouse	NULL
pore-forming	NULL
protein	NULL
(	NULL
perforin	NULL
)	NULL
gene	NULL
:	NULL
analysis	NULL
of	NULL
transcription	NULL
initiation	NULL
site	NULL
,	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
,	NULL
and	NULL
alternative	NULL
splicing	NULL
of	NULL
5	NULL
'	NULL
untranslated	NULL
regions	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:813-822.	NULL
.	NULL

Young	NULL
,	NULL
J.	NULL
D.-E.	NULL
1989	NULL
.	NULL

Killing	NULL
of	NULL
target	NULL
cells	NULL
by	NULL
lymphocytes	NULL
:	NULL
a	NULL
mechanistic	NULL
view	NULL
.	NULL

Physiol	NULL
.	NULL

Rev	NULL
.	NULL

69:250-314	NULL
.	NULL

Zychlinsky	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Karim	NULL
,	NULL
R.	NULL
Nonacs	NULL
,	NULL
and	NULL
J.	NULL
D.-E.	NULL
Young	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
homogeneous	NULL
population	NULL
of	NULL
lymphokine-activated	NULL
killer	NULL
(	NULL
LAK	NULL
)	NULL
cells	NULL
is	NULL
incapable	NULL
of	NULL
killing	NULL
virus-	NULL
,	NULL
bacteria-	NULL
,	NULL
or	NULL
parasite-infected	NULL
macrophages	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

125:261-267	NULL
.	NULL

